<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FMTOF="http://femto-tech.com/20260630"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fmtof-20260630.xsd" xlink:type="simple"/>
    <context id="From2026-01-01to2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-04-012026-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-04-172025-04-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <startDate>2025-04-17</startDate>
            <endDate>2025-04-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_BeyondSolutionLtdMember_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:BeyondSolutionLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2021-03-29_custom_FormerShareholderMember_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:FormerShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-29</instant>
        </period>
    </context>
    <context id="AsOf2022-09-22_custom_ZigiCarmelInitiativesAndInvestmentsLtdMember_custom_FormerShareholderMember_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:ZigiCarmelInitiativesAndInvestmentsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">FMTOF:FormerShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-22</instant>
        </period>
    </context>
    <context id="AsOf2022-09-22_custom_ZigiCarmelInitiativesAndInvestmentsLtdMember_custom_FormerShareholderMember_custom_ShareExchangeAgreementMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:ZigiCarmelInitiativesAndInvestmentsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">FMTOF:FormerShareholderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-22</instant>
        </period>
    </context>
    <context id="From2025-02-282025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_BeyondSolutionLtdMember_ifrs-full_RelatedPartiesMember_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:BeyondSolutionLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-03-272026-03-27_custom_GiladMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:GiladMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-27</startDate>
            <endDate>2026-03-27</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-27_custom_GiladMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:GiladMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-27</instant>
        </period>
    </context>
    <context id="AsOf2026-03-27_custom_FourEqualQuarterlyInstalmentsMember_custom_GiladMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:GiladMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">FMTOF:FourEqualQuarterlyInstalmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-27</instant>
        </period>
    </context>
    <context id="AsOf2026-03-30_custom_GiladMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:GiladMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_GiladMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:GiladMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_ThreerEqualQuarterlyInstalmentsMember_custom_GiladMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">FMTOF:GiladMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">FMTOF:ThreerEqualQuarterlyInstalmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">FMTOF:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">FMTOF:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">FMTOF:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">FMTOF:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">FMTOF:PatentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">FMTOF:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ResearchAndDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">FMTOF:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_ProfessionalFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">FMTOF:ProfessionalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_ProfessionalFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">FMTOF:ProfessionalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_ifrs-full_SellingGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_ifrs-full_SellingGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_SubordinateVotingSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="AsOf2026-03-30_custom_SubordinateVotingSharesMember_custom_VendorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:VendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-30</instant>
        </period>
    </context>
    <context id="AsOf2026-04-09_custom_DirectorsMember_custom_EventsAfterReportingPeriodMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">FMTOF:EventsAfterReportingPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-09</instant>
        </period>
    </context>
    <context id="AsOf2025-01-03_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="AsOf2025-01-03_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="AsOf2025-01-06_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-06</instant>
        </period>
    </context>
    <context id="AsOf2025-01-06_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-07_custom_SubordinateVotingSharesMember_custom_DirectorsAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:DirectorsAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-07</instant>
        </period>
    </context>
    <context id="AsOf2025-02-07_custom_SubordinateVotingSharesMember_custom_DirectorsAndConsultantsMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:DirectorsAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-07</instant>
        </period>
    </context>
    <context id="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-25</instant>
        </period>
    </context>
    <context id="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-25</instant>
        </period>
    </context>
    <context id="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-25</instant>
        </period>
    </context>
    <context id="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesAWarrantsMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-25</instant>
        </period>
    </context>
    <context id="From2025-02-282025-02-28_custom_PrivatePlacementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:PrivatePlacementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:PrivatePlacementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:PrivatePlacementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:PrivatePlacementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:PrivatePlacementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfContractsAxis">FMTOF:PrivatePlacementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-04-21_custom_SubordinateVotingSharesMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:DirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-21</instant>
        </period>
    </context>
    <context id="AsOf2025-04-21_custom_SubordinateVotingSharesMember_custom_DirectorsMember_custom_PostReverseSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">FMTOF:PostReverseSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-21</instant>
        </period>
    </context>
    <context id="AsOf2025-04-22_custom_SubordinateVotingSharesMember_custom_CEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:CEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-22</instant>
        </period>
    </context>
    <context id="AsOf2025-04-25_custom_SubordinateVotingSharesMember_custom_DirectorsAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">FMTOF:DirectorsAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-25</instant>
        </period>
    </context>
    <context id="AsOf2025-04-24_custom_SubordinateVotingSharesMember_custom_PreFundedWarrantsAndSeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">FMTOF:PreFundedWarrantsAndSeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-24</instant>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_SubordinateVotingSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">FMTOF:SubordinateVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_SoftwareDevelopmentRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SoftwareDevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_SoftwareDevelopmentRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SoftwareDevelopmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_SenseraDevicesAndCapsulesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SenseraDevicesAndCapsulesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_SenseraDevicesAndCapsulesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SenseraDevicesAndCapsulesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_SoftwareLicensingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SoftwareLicensingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_SoftwareLicensingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SoftwareLicensingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_SoftwareSupportRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SoftwareSupportRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_SoftwareSupportRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:SoftwareSupportRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CloudHostingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:CloudHostingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CloudHostingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">FMTOF:CloudHostingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_RevenueTransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">FMTOF:RevenueTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_RevenueTransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">FMTOF:RevenueTransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_RevenueTransferredAtPointInTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">FMTOF:RevenueTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_RevenueTransferredAtPointInTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TimingOfTransferOfGoodsOrServicesAxis">FMTOF:RevenueTransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-06-30_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">FMTOF:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-06-30_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001888151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">FMTOF:CustomerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="CAD">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="CADPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentType contextRef="From2026-01-01to2026-06-30" id="Fact000023">6-K</dei:DocumentType>
    <dei:DocumentFiscalYearFocus contextRef="From2026-01-01to2026-06-30" id="Fact000024">2026</dei:DocumentFiscalYearFocus>
    <dei:EntityFileNumber contextRef="From2026-01-01to2026-06-30" id="Fact000025">001-41408</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2026-01-01to2026-06-30" id="Fact000026">FEMTO TECHNOLOGIES INC.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="From2026-01-01to2026-06-30" id="Fact000027">7000 Akko Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2026-01-01to2026-06-30" id="Fact000028">Kiryat Motzkin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2026-01-01to2026-06-30" id="Fact000029">IL</dei:EntityAddressCountry>
    <dei:AmendmentFlag contextRef="From2026-01-01to2026-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2026-01-01to2026-06-30" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate contextRef="From2026-01-01to2026-06-30" id="Fact000005">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2026-01-01to2026-06-30" id="Fact000006">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2026-01-01to2026-06-30" id="Fact000007">0001888151</dei:EntityCentralIndexKey>
    <FMTOF:EquityMethodInvestment
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0053"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0080"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:CurrentDerivativeForSettlementAgreement
      contextRef="AsOf2026-06-30"
      id="xdx2ixbrl0085"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:GainFromWarrantsRevaluation
      contextRef="From2026-04-012026-06-30"
      id="xdx2ixbrl0184"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:GainFromWarrantsRevaluation
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0186"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:LossFromSettlementAgreementRevaluation
      contextRef="From2026-04-012026-06-30"
      id="xdx2ixbrl0189"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:LossFromSettlementAgreementRevaluation
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0191"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2026-04-012026-06-30"
      id="xdx2ixbrl0214"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0216"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0294"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0295"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0296"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0297"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0303"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0304"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0305"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0306"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForCashlessExerciseOfWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0310"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForCashlessExerciseOfWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0311"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForCashlessExerciseOfWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0312"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForCashlessExerciseOfWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0313"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0318"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0319"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0320"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0321"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0326"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0327"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0328"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0329"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForServices
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0335"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForServices
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0336"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForServices
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0337"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForServices
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0338"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0344"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0346"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0347"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ShareRepurchaseValue
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0353"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ShareRepurchaseValue
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0354"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ShareRepurchaseValue
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0355"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ShareRepurchaseValue
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0356"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0361"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0363"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0365"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForAcquisition
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0387"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForAcquisition
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0388"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForAcquisition
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0389"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharesIssuedForAcquisition
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0390"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0396"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0398"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0399"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0404"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0405"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0406"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0407"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0411"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      id="xdx2ixbrl0412"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0413"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      id="xdx2ixbrl0414"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0418"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0420"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0422"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0446"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:LossFromRevaluationOfWarrants
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0461"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AdjustmentsForIncreaseDecreaseInInventory
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0480"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0501"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SharePrepurchased
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0509"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0512"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ReceiptOfLoans
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0515"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:RepaymentOfLongTermLoan
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0518"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0521"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:CashInterestPaid
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0539"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossAdditions
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0642"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossAdditions
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0644"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossAdditions
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0646"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossImpairments
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0648"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0654"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0656"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0658"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossAdditions
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0666"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossAdditions
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0668"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossAdditions
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0670"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0672"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0674"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0676"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0686"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfDepreciation
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0690"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfDepreciation
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0692"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfDepreciation
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0694"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0696"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0698"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0700"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0704"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfDepreciation
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0708"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfDepreciation
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0710"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualPropertiesOfDepreciation
      contextRef="From2026-01-012026-06-30_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl0712"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      id="xdx2ixbrl0716"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsExcludingGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0720"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:IntangibleAssetsExcludingGoodwill
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl0726"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_SenseraDevicesAndCapsulesMember"
      id="xdx2ixbrl0851"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SenseraCosts
      contextRef="From2025-01-012025-06-30"
      id="xdx2ixbrl0909"
      unitRef="CAD"
      xsi:nil="true"/>
    <FMTOF:SubcontractorsExpenseRecovery
      contextRef="From2026-01-01to2026-06-30"
      id="xdx2ixbrl0911"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000034"
      unitRef="CAD">13002242</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000035"
      unitRef="CAD">15231108</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000037"
      unitRef="CAD">115708</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000038"
      unitRef="CAD">105911</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000040"
      unitRef="CAD">154507</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000041"
      unitRef="CAD">528991</ifrs-full:OtherReceivables>
    <ifrs-full:InventoriesTotal
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000043"
      unitRef="CAD">169649</ifrs-full:InventoriesTotal>
    <ifrs-full:InventoriesTotal
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="CAD">163414</ifrs-full:InventoriesTotal>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000046"
      unitRef="CAD">92203</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="CAD">40082</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000049"
      unitRef="CAD">13534309</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000050"
      unitRef="CAD">16069506</ifrs-full:CurrentAssets>
    <FMTOF:EquityMethodInvestment
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000052"
      unitRef="CAD">2024925</FMTOF:EquityMethodInvestment>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000055"
      unitRef="CAD">19800767</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="CAD">19800767</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000058"
      unitRef="CAD">3578</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="CAD">2805</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Assets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000061"
      unitRef="CAD">35363579</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000062"
      unitRef="CAD">35873078</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000070"
      unitRef="CAD">131305</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000071"
      unitRef="CAD">317537</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000073"
      unitRef="CAD">151910</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000074"
      unitRef="CAD">113892</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000076"
      unitRef="CAD">95354</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="CAD">145404</ifrs-full:ContractLiabilities>
    <ifrs-full:OtherCurrentPayables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="CAD">1065750</ifrs-full:OtherCurrentPayables>
    <FMTOF:EnhancedVotingPreferenceShares
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000082"
      unitRef="CAD">37302</FMTOF:EnhancedVotingPreferenceShares>
    <FMTOF:EnhancedVotingPreferenceShares
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000083"
      unitRef="CAD">35979</FMTOF:EnhancedVotingPreferenceShares>
    <FMTOF:CurrentDerivativeForSettlementAgreement
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000086"
      unitRef="CAD">191884</FMTOF:CurrentDerivativeForSettlementAgreement>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000088"
      unitRef="CAD">1481621</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000089"
      unitRef="CAD">804696</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentWarrantLiability
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000091"
      unitRef="CAD">6015</ifrs-full:NoncurrentWarrantLiability>
    <ifrs-full:NoncurrentWarrantLiability
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000092"
      unitRef="CAD">5802</ifrs-full:NoncurrentWarrantLiability>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000094"
      unitRef="CAD">42971</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:NoncurrentProvisionsForEmployeeBenefits
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000095"
      unitRef="CAD">62212</ifrs-full:NoncurrentProvisionsForEmployeeBenefits>
    <ifrs-full:Liabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000097"
      unitRef="CAD">1530607</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000098"
      unitRef="CAD">872710</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000103"
      unitRef="CAD">94560825</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000104"
      unitRef="CAD">94159660</ifrs-full:IssuedCapital>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000106"
      unitRef="CAD">906164</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000107"
      unitRef="CAD">1096335</ifrs-full:ReserveOfSharebasedPayments>
    <FMTOF:TranslationDifferencesReserve
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000109"
      unitRef="CAD">-8492</FMTOF:TranslationDifferencesReserve>
    <FMTOF:TranslationDifferencesReserve
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000110"
      unitRef="CAD">-350710</FMTOF:TranslationDifferencesReserve>
    <ifrs-full:CapitalReserve
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000112"
      unitRef="CAD">104156</ifrs-full:CapitalReserve>
    <ifrs-full:CapitalReserve
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000113"
      unitRef="CAD">75215</ifrs-full:CapitalReserve>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000115"
      unitRef="CAD">-61729681</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000116"
      unitRef="CAD">-59980132</ifrs-full:RetainedEarnings>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000118"
      unitRef="CAD">33832972</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000119"
      unitRef="CAD">35000368</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000121"
      unitRef="CAD">35363579</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000122"
      unitRef="CAD">35873078</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000124"
      unitRef="CAD">249116</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000125"
      unitRef="CAD">205229</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000126"
      unitRef="CAD">488405</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000127"
      unitRef="CAD">407921</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000129"
      unitRef="CAD">220566</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000130"
      unitRef="CAD">185501</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000131"
      unitRef="CAD">400048</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000132"
      unitRef="CAD">373208</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000134"
      unitRef="CAD">28550</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000135"
      unitRef="CAD">19728</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000136"
      unitRef="CAD">88357</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000137"
      unitRef="CAD">34713</ifrs-full:GrossProfit>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000139"
      unitRef="CAD">359071</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000140"
      unitRef="CAD">345210</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000141"
      unitRef="CAD">702284</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000142"
      unitRef="CAD">840657</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000144"
      unitRef="CAD">97348</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000145"
      unitRef="CAD">924634</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000146"
      unitRef="CAD">185794</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000147"
      unitRef="CAD">1769403</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000149"
      unitRef="CAD">135</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000150"
      unitRef="CAD">625</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000151"
      unitRef="CAD">262</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000152"
      unitRef="CAD">1285</ifrs-full:DepreciationExpense>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000154"
      unitRef="CAD">71604</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000155"
      unitRef="CAD">1389094</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000156"
      unitRef="CAD">71604</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000157"
      unitRef="CAD">2052346</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000159"
      unitRef="CAD">518900</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000160"
      unitRef="CAD">1117168</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000161"
      unitRef="CAD">938882</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000162"
      unitRef="CAD">1581461</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000164"
      unitRef="CAD">80745</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000165"
      unitRef="CAD">551118</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000166"
      unitRef="CAD">363714</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000167"
      unitRef="CAD">1213074</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:OperatingExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000169"
      unitRef="CAD">1127803</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000170"
      unitRef="CAD">4327849</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000171"
      unitRef="CAD">2262540</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000172"
      unitRef="CAD">7458226</ifrs-full:OperatingExpense>
    <ifrs-full:OtherGainsLosses
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000174"
      unitRef="CAD">-1099253</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000175"
      unitRef="CAD">-4308121</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000176"
      unitRef="CAD">-2174183</ifrs-full:OtherGainsLosses>
    <ifrs-full:OtherGainsLosses
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000177"
      unitRef="CAD">-7423513</ifrs-full:OtherGainsLosses>
    <FMTOF:GainFromWarrantsRevaluation
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000185"
      unitRef="CAD">37703771</FMTOF:GainFromWarrantsRevaluation>
    <FMTOF:GainFromWarrantsRevaluation
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000187"
      unitRef="CAD">30389592</FMTOF:GainFromWarrantsRevaluation>
    <FMTOF:LossFromSettlementAgreementRevaluation
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000190"
      unitRef="CAD">843587</FMTOF:LossFromSettlementAgreementRevaluation>
    <FMTOF:LossFromSettlementAgreementRevaluation
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000192"
      unitRef="CAD">971687</FMTOF:LossFromSettlementAgreementRevaluation>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000194"
      unitRef="CAD">135125</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000195"
      unitRef="CAD">-1014255</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000196"
      unitRef="CAD">148489</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000197"
      unitRef="CAD">-1155417</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:FinanceIncome
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000199"
      unitRef="CAD">123239</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000200"
      unitRef="CAD">253778</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000201"
      unitRef="CAD">276145</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000202"
      unitRef="CAD">280743</ifrs-full:FinanceIncome>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000204"
      unitRef="CAD">258364</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000205"
      unitRef="CAD">36099707</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000206"
      unitRef="CAD">424634</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000207"
      unitRef="CAD">28543231</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000209"
      unitRef="CAD">-840889</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000210"
      unitRef="CAD">31791586</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000211"
      unitRef="CAD">-1749549</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000212"
      unitRef="CAD">21119718</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000215"
      unitRef="CAD">7416</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000217"
      unitRef="CAD">12967</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000219"
      unitRef="CAD">-840889</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000220"
      unitRef="CAD">31784170</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000221"
      unitRef="CAD">-1749549</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000222"
      unitRef="CAD">21106751</ifrs-full:ProfitLoss>
    <FMTOF:RemeasurementOfDefinedBenefitPlanNet
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000229"
      unitRef="CAD">14924</FMTOF:RemeasurementOfDefinedBenefitPlanNet>
    <FMTOF:RemeasurementOfDefinedBenefitPlanNet
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000230"
      unitRef="CAD">2551</FMTOF:RemeasurementOfDefinedBenefitPlanNet>
    <FMTOF:RemeasurementOfDefinedBenefitPlanNet
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000231"
      unitRef="CAD">28941</FMTOF:RemeasurementOfDefinedBenefitPlanNet>
    <FMTOF:RemeasurementOfDefinedBenefitPlanNet
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000232"
      unitRef="CAD">5171</FMTOF:RemeasurementOfDefinedBenefitPlanNet>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000234"
      unitRef="CAD">108049</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000235"
      unitRef="CAD">-105388</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000236"
      unitRef="CAD">342218</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000237"
      unitRef="CAD">-59143</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000239"
      unitRef="CAD">122973</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000240"
      unitRef="CAD">-102837</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000241"
      unitRef="CAD">371159</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000242"
      unitRef="CAD">-53972</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-04-012026-06-30"
      decimals="0"
      id="Fact000244"
      unitRef="CAD">-717916</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-04-012025-06-30"
      decimals="0"
      id="Fact000245"
      unitRef="CAD">31681333</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000246"
      unitRef="CAD">-1378390</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000247"
      unitRef="CAD">21052779</ifrs-full:ComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2026-04-012026-06-30"
      decimals="INF"
      id="Fact000249"
      unitRef="CADPShares">-0.81</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2026-04-012026-06-30"
      decimals="INF"
      id="Fact000251"
      unitRef="CADPShares">-0.81</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-04-012025-06-30"
      decimals="INF"
      id="Fact000253"
      unitRef="CADPShares">44.52</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-04-012025-06-30"
      decimals="INF"
      id="Fact000255"
      unitRef="CADPShares">44.52</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000257"
      unitRef="CADPShares">-1.84</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000259"
      unitRef="CADPShares">-1.84</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000261"
      unitRef="CADPShares">58.57</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000263"
      unitRef="CADPShares">58.57</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:WeightedAverageShares
      contextRef="From2026-04-012026-06-30"
      decimals="INF"
      id="Fact000265"
      unitRef="Shares">1037171</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2026-04-012026-06-30"
      decimals="INF"
      id="Fact000267"
      unitRef="Shares">1037171</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-04-012025-06-30"
      decimals="INF"
      id="Fact000269"
      unitRef="Shares">713873</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2025-04-012025-06-30"
      decimals="INF"
      id="Fact000271"
      unitRef="Shares">713873</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000273"
      unitRef="Shares">950565</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000275"
      unitRef="Shares">950565</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000277"
      unitRef="Shares">360389</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2025-01-012025-06-30"
      decimals="INF"
      id="Fact000279"
      unitRef="Shares">360389</ifrs-full:AdjustedWeightedAverageShares>
    <FMTOF:StockholdersEquityReverseStockSplitDescription contextRef="From2025-04-172025-04-17" id="Fact000282">one (1) for five hundreds (500) reverse stock split</FMTOF:StockholdersEquityReverseStockSplitDescription>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000291"
      unitRef="Shares">1311</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000284"
      unitRef="CAD">76391417</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000285"
      unitRef="CAD">-164312</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000286"
      unitRef="CAD">1043586</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      decimals="0"
      id="Fact000287"
      unitRef="CAD">23534</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000288"
      unitRef="CAD">-72902426</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000289"
      unitRef="CAD">4391799</ifrs-full:Equity>
    <FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNetShares
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000300"
      unitRef="Shares">4167</FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNetShares>
    <FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000293"
      unitRef="CAD">20852213</FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet>
    <FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000298"
      unitRef="CAD">20852213</FMTOF:SharesPrefundedWarrantsAndWarrantsIssuedForCashNet>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000302"
      unitRef="CAD">-20552190</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000307"
      unitRef="CAD">-20552190</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
    <FMTOF:SharesIssuedForCashlessExerciseOfWarrantsShares
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000316"
      unitRef="Shares">652767</FMTOF:SharesIssuedForCashlessExerciseOfWarrantsShares>
    <FMTOF:SharesIssuedForCashlessExerciseOfWarrants
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000309"
      unitRef="CAD">14531624</FMTOF:SharesIssuedForCashlessExerciseOfWarrants>
    <FMTOF:SharesIssuedForCashlessExerciseOfWarrants
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000314"
      unitRef="CAD">14531624</FMTOF:SharesIssuedForCashlessExerciseOfWarrants>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000322"
      unitRef="CAD">21106751</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000323"
      unitRef="CAD">21106751</ifrs-full:ProfitLoss>
    <FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreementShares
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000332"
      unitRef="Shares">114800</FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreementShares>
    <FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000325"
      unitRef="CAD">830452</FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement>
    <FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000330"
      unitRef="CAD">830452</FMTOF:NumberOfSharesIssuedPursuantToSettlementAgreement>
    <FMTOF:NumberOfSharesIssuedForServices
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000341"
      unitRef="Shares">87458</FMTOF:NumberOfSharesIssuedForServices>
    <FMTOF:SharesIssuedForServices
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000334"
      unitRef="CAD">2006196</FMTOF:SharesIssuedForServices>
    <FMTOF:SharesIssuedForServices
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000339"
      unitRef="CAD">2006196</FMTOF:SharesIssuedForServices>
    <FMTOF:IncreaseDecreaseThroughSharebasedPaymentTransactionsShares
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000350"
      unitRef="Shares">6</FMTOF:IncreaseDecreaseThroughSharebasedPaymentTransactionsShares>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000343"
      unitRef="CAD">183572</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000345"
      unitRef="CAD">-137422</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000348"
      unitRef="CAD">46150</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <FMTOF:SharesRepurchased
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000359"
      unitRef="Shares">-19747</FMTOF:SharesRepurchased>
    <FMTOF:ShareRepurchaseValue
      contextRef="From2025-01-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000352"
      unitRef="CAD">-127785</FMTOF:ShareRepurchaseValue>
    <FMTOF:ShareRepurchaseValue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000357"
      unitRef="CAD">-127785</FMTOF:ShareRepurchaseValue>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000362"
      unitRef="CAD">-59143</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      decimals="0"
      id="Fact000364"
      unitRef="CAD">5171</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000366"
      unitRef="CAD">-53972</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000375"
      unitRef="Shares">840762</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000368"
      unitRef="CAD">94115499</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000369"
      unitRef="CAD">-223455</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000370"
      unitRef="CAD">906164</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      decimals="0"
      id="Fact000371"
      unitRef="CAD">28705</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000372"
      unitRef="CAD">-51795675</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000373"
      unitRef="CAD">43031238</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000384"
      unitRef="Shares">861111</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000377"
      unitRef="CAD">94159660</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000378"
      unitRef="CAD">-350710</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000379"
      unitRef="CAD">1096335</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      decimals="0"
      id="Fact000380"
      unitRef="CAD">75215</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000381"
      unitRef="CAD">-59980132</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000382"
      unitRef="CAD">35000368</ifrs-full:Equity>
    <FMTOF:NumberOfSharesIssuedForAcquisition
      contextRef="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000393"
      unitRef="Shares">169811</FMTOF:NumberOfSharesIssuedForAcquisition>
    <FMTOF:SharesIssuedForAcquisition
      contextRef="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000386"
      unitRef="CAD">139390</FMTOF:SharesIssuedForAcquisition>
    <FMTOF:SharesIssuedForAcquisition
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000391"
      unitRef="CAD">139390</FMTOF:SharesIssuedForAcquisition>
    <FMTOF:IncreaseDecreaseThroughSharebasedPaymentTransactionsShares
      contextRef="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000402"
      unitRef="Shares">6852</FMTOF:IncreaseDecreaseThroughSharebasedPaymentTransactionsShares>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2026-01-012026-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000395"
      unitRef="CAD">261775</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000397"
      unitRef="CAD">-190171</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000400"
      unitRef="CAD">71604</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000408"
      unitRef="CAD">-1749549</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000409"
      unitRef="CAD">-1749549</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-012026-06-30_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000415"
      unitRef="CAD">-1749549</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000416"
      unitRef="CAD">-1749549</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000419"
      unitRef="CAD">342218</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-012026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      decimals="0"
      id="Fact000421"
      unitRef="CAD">28941</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000423"
      unitRef="CAD">371159</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2026-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000432"
      unitRef="Shares">1037774</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000425"
      unitRef="CAD">94299050</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30_ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"
      decimals="0"
      id="Fact000426"
      unitRef="CAD">-8492</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000427"
      unitRef="CAD">906164</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30_ifrs-full_ReserveOfInsuranceFinanceIncomeExpensesFromInsuranceContractsIssuedExcludedFromProfitOrLossThatWillBeReclassifiedToProfitOrLossMember"
      decimals="0"
      id="Fact000428"
      unitRef="CAD">104156</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000429"
      unitRef="CAD">-61729681</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000430"
      unitRef="CAD">33832972</ifrs-full:Equity>
    <FMTOF:StockholdersEquityReverseStockSplitDescription contextRef="From2025-04-172025-04-17" id="Fact000435">one (1) for five hundreds (500) reverse stock split</FMTOF:StockholdersEquityReverseStockSplitDescription>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000440"
      unitRef="CAD">-1749549</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000441"
      unitRef="CAD">21106751</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000447"
      unitRef="CAD">1774</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000449"
      unitRef="CAD">71604</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000450"
      unitRef="CAD">2052346</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000452"
      unitRef="CAD">1384</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000453"
      unitRef="CAD">2102</ifrs-full:AdjustmentsForDepreciationExpense>
    <FMTOF:GainLossFromSettlementAgreementRevaluation
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000455"
      unitRef="CAD">191884</FMTOF:GainLossFromSettlementAgreementRevaluation>
    <FMTOF:GainLossFromSettlementAgreementRevaluation
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000456"
      unitRef="CAD">-971687</FMTOF:GainLossFromSettlementAgreementRevaluation>
    <FMTOF:AdjustmentsForChangeInBenefitsToEmployees
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000458"
      unitRef="CAD">9700</FMTOF:AdjustmentsForChangeInBenefitsToEmployees>
    <FMTOF:AdjustmentsForChangeInBenefitsToEmployees
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000459"
      unitRef="CAD">8731</FMTOF:AdjustmentsForChangeInBenefitsToEmployees>
    <FMTOF:LossFromRevaluationOfWarrants
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000462"
      unitRef="CAD">-30389592</FMTOF:LossFromRevaluationOfWarrants>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000464"
      unitRef="CAD">-147601</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000465"
      unitRef="CAD">645718</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000470"
      unitRef="CAD">-9797</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000471"
      unitRef="CAD">2314</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000473"
      unitRef="CAD">374484</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000474"
      unitRef="CAD">-57518</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000476"
      unitRef="CAD">-186232</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000477"
      unitRef="CAD">-253675</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <FMTOF:AdjustmentsForIncreaseDecreaseInInventory
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000479"
      unitRef="CAD">-6235</FMTOF:AdjustmentsForIncreaseDecreaseInInventory>
    <FMTOF:AdjustmentsForChangeInDeferredRevenue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000482"
      unitRef="CAD">50050</FMTOF:AdjustmentsForChangeInDeferredRevenue>
    <FMTOF:AdjustmentsForChangeInDeferredRevenue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000483"
      unitRef="CAD">54434</FMTOF:AdjustmentsForChangeInDeferredRevenue>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000485"
      unitRef="CAD">-52121</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000486"
      unitRef="CAD">-120309</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <FMTOF:AdjustmentsForIncreaseDecreaseInRelatedParties
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000488"
      unitRef="CAD">38018</FMTOF:AdjustmentsForIncreaseDecreaseInRelatedParties>
    <FMTOF:AdjustmentsForIncreaseDecreaseInRelatedParties
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000489"
      unitRef="CAD">188123</FMTOF:AdjustmentsForIncreaseDecreaseInRelatedParties>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000491"
      unitRef="CAD">-1898279</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000492"
      unitRef="CAD">-5895982</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000497"
      unitRef="CAD">1820</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000498"
      unitRef="CAD">1290</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000500"
      unitRef="CAD">819785</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000503"
      unitRef="CAD">-821605</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000504"
      unitRef="CAD">-1290</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <FMTOF:SharePrepurchased
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000510"
      unitRef="CAD">-127785</FMTOF:SharePrepurchased>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000513"
      unitRef="CAD">20734691</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <FMTOF:ReceiptOfLoans
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000516"
      unitRef="CAD">81057</FMTOF:ReceiptOfLoans>
    <FMTOF:RepaymentOfLongTermLoan
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000519"
      unitRef="CAD">30184</FMTOF:RepaymentOfLongTermLoan>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000522"
      unitRef="CAD">20657779</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000524"
      unitRef="CAD">-2719884</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000525"
      unitRef="CAD">14760507</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000527"
      unitRef="CAD">491018</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000528"
      unitRef="CAD">-706430</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000530"
      unitRef="CAD">15231108</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000531"
      unitRef="CAD">4617034</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000533"
      unitRef="CAD">13002242</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000534"
      unitRef="CAD">18671111</ifrs-full:CashAndCashEquivalents>
    <FMTOF:CashInterestPaid
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000540"
      unitRef="CAD">1774</FMTOF:CashInterestPaid>
    <FMTOF:DisclosureOfNatureOfOperationsAndGoingConcernExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000542">&lt;p id="xdx_80F_ecustom--DisclosureOfNatureOfOperationsAndGoingConcernExplanatory_zQISDi7HFSRf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; &lt;span id="xdx_82C_zrpZqfLCazh9"&gt;NATURE OF OPERATIONS AND GOING CONCERN&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Femto
Technologies Inc. (Formerly known as BYND Cannasoft Enterprises Inc.) (the &#x201c;Company&#x201d; or &#x201c;Femto&#x201d;) is a Canadian
company which was amalgamated under the Business Corporations Act (British Columbia) on March 29, 2021. The Company&#x2019;s registered
address is 2264 East 11&lt;sup&gt;th&lt;/sup&gt; Avenue, Vancouver, Canada.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently operates only in Israel and through its subsidiaries develops, markets and sells a proprietary client relationship
management software known as &#x201c;Benefit CRM&#x201d; and in addition the Company has developed the Sensera device (formerly the EZ-G
device), a unique, patent pending device that, combined with proprietary software (provisional application), regulates the flow of lubricants
and oils into the soft tissues of the female sexual organs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 29, 2021, the Company completed the business combination transactions with BYND &#x2013; Beyond Solutions Ltd. (&#x201c;BYND&#x201d;).
As a result of the business combination transactions, BYND became a wholly owned subsidiary of the Company. This transaction is accounted
for as a reverse asset acquisition of the Company by BYND (&#x201c;RTO&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 29, 2021, BYND completed the share exchange agreement with B.Y.B.Y. As a result of the share exchange agreement, BYND holds &lt;span id="xdx_90B_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210329__ifrs-full--BusinessCombinationsAxis__custom--BeyondSolutionLtdMember__ifrs-full--TypesOfContractsAxis__custom--ShareExchangeAgreementMember_ztmeU9y73r43" title="Ownership interest"&gt;74&lt;/span&gt;%
ownership interest in B.Y.B.Y. One of the former shareholders holds the remaining &lt;span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210329__ifrs-full--BusinessCombinationsAxis__custom--FormerShareholderMember__ifrs-full--TypesOfContractsAxis__custom--ShareExchangeAgreementMember_zDsqBviSxWe6" title="Ownership interest"&gt;26&lt;/span&gt;% ownership interest in B.Y.B.Y. in trust for BYND,
for the purpose to comply with Israeli Cannabis Laws regarding the ownership of medical cannabis license rights This transaction was
accounted for as asset acquisition according to IFRS 2 Share-based Payment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 22, 2022, the Company and the former shareholder of Zigi Carmel Initiatives and Investments Ltd. (&#x201c;ZC&#x201d;) entered
into a share exchange agreement, whereby the Company would acquire &lt;span id="xdx_90F_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20220922__ifrs-full--BusinessCombinationsAxis__custom--ZigiCarmelInitiativesAndInvestmentsLtdMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerShareholderMember__ifrs-full--TypesOfContractsAxis__custom--ShareExchangeAgreementMember_zUrAl7lonJ9i" title="Ownership interest"&gt;100&lt;/span&gt;% ownership interest in ZC from the former shareholder in exchange
for &lt;span id="xdx_90B_eifrs-full--NumberOfInstrumentsOrInterestsIssuedOrIssuable_iI_pid_uShares_c20220922__ifrs-full--BusinessCombinationsAxis__custom--ZigiCarmelInitiativesAndInvestmentsLtdMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerShareholderMember__ifrs-full--TypesOfContractsAxis__custom--ShareExchangeAgreementMember_zpKpk2UiExl7" title="Number of shares issued"&gt;7,920,000&lt;/span&gt; subordinate voting shares (&lt;span id="xdx_909_eifrs-full--NumberOfInstrumentsOrInterestsIssuedOrIssuable_iI_pid_uShares_c20220922__ifrs-full--BusinessCombinationsAxis__custom--ZigiCarmelInitiativesAndInvestmentsLtdMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FormerShareholderMember__ifrs-full--TypesOfContractsAxis__custom--ShareExchangeAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PostReverseSplitMember_ze0sKjLChpti" title="Number of shares issued"&gt;2,452&lt;/span&gt; subordinate voting shares post reverse splits) of the Company. The share exchange agreement
was executed and fully completed on September 22, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
July 22, 2024, the Company changed its name to Femto Technologies Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Reverse
stock splits&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 17, 2025, the Company announced a &lt;span id="xdx_907_ecustom--StockholdersEquityReverseStockSplitDescription_c20250417__20250417_zBZDHJ9fulDc" title="Reverse stock split"&gt;one (1) for five hundreds (500) reverse stock split&lt;/span&gt; of its outstanding subordinate voting shares
that became effective on April 22, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
shares, stock options, share purchase warrants, RSU&#x2019;s and per share information in these consolidated financial statements have
been restated to reflect the reverse stock splits on a retroactive basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The
Lion&#x2019;s Roar Operation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2026, after the reporting date, &#x201c;The Lion&#x2019;s Roar Operation&#x201d; (the &#x201c;Operation&#x201d;) commenced, a
joint military operation by the United States and Israel involving attacks in Iran.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
response, Iran launched ballistic missiles and unmanned aerial vehicles (UAVs) toward Israel and certain states in the Persian Gulf region.
These events have resulted in civilian casualties and property damage in Israel. Additionally, Hezbollah, a terrorist organization in
Lebanon, joined the attacks against Israel and Israel has started military operations in Lebanon.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; NATURE OF OPERATIONS AND GOING CONCERN (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the commencement of the Operation, Israel&#x2019;s Home Front Command announced a &#x201c;special home front situation&#x201d; and updated
safety guidelines that include, among other measures, restrictions on passenger flights, limitations on gatherings, broad reserve recruitment,
and temporary closure of certain businesses, which has contributed to a partial reduction in economic activity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
this is an event beyond the Company&#x2019;s control and characterized by uncertainty, in particular as to when the Operation will end,
as of the approval date of these consolidated financial statements, the Company is unable to predict the intensity of the impact of the
Operation on the Company&#x2019;s financial condition and the results of BYND operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of approval of these consolidated financial statements, a ceasefire has been announced. While this development may contribute
to a gradual easing of certain restrictions and a recovery in economic activity, significant uncertainty remains regarding the stability
of the ceasefire and the potential for renewed escalation. Accordingly, the ultimate impact of the operation and related developments
on the Company&#x2019;s financial condition and results of operations remains uncertain, and the Company continues to monitor the situation
closely.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Going
Concern&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended June 30, 2026, the Company incurred a net loss of $&lt;span id="xdx_90D_eifrs-full--ProfitLoss_iN_di_c20260101__20260630_zBunuP5sUvzl" title="Net income loss"&gt;1,749,549&lt;/span&gt;, generated negative cash flow from operating activities
of $&lt;span id="xdx_904_eifrs-full--CashFlowsFromUsedInOperations_iN_di_c20260101__20260630_zwKu8DTF0BTh" title="Cash flows from (used in) operations"&gt;1,898,279&lt;/span&gt; and an accumulated deficit of $&lt;span id="xdx_90B_eifrs-full--RetainedEarnings_iNI_di_c20260630_zIqj13TUHEal" title="Accumulated Deficit"&gt;61,729,681&lt;/span&gt; as at June 30, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2025, the Company completed the transactions contemplated under a securities purchase agreement (the &#x201c;Purchase Agreement&#x201d;)
with institutional investors for the purchase and sale of subordinate voting shares and warrants at a price of US$&lt;span id="xdx_90F_ecustom--PrefundedAndInvestorWarrantsPricePerShare_pid_uUSDPShares_c20250228__20250228_zUiNAPBNk6v6" title="Prefunded and investor warrants price per share"&gt;4.17&lt;/span&gt; per subordinate
voting unit for total consideration of approximately US$&lt;span id="xdx_90C_ecustom--PurchaseAndSaleOfInstitutionalInvestors_pn5n6_uUSD_c20250228__20250228_z8NprzrjVjt2" title="Purchase and sale of institutional investors"&gt;17.0&lt;/span&gt; million ($&lt;span id="xdx_905_ecustom--PurchaseAndSaleOfInstitutionalInvestors_uCAD_c20250228__20250228_zjfhCZVuNPJ6" title="Purchase and sale of institutional investors"&gt;20,552,190&lt;/span&gt; net).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company plans to invest in marketing and sales efforts for the Sensera device, reduce expenses of research and development and maintain
other expenditures at the same level compared to the year ended December 31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has $&lt;span id="xdx_90B_eifrs-full--CashAndCashEquivalents_iI_c20260630_z1b3B1rGdDh" title="Cash on hand"&gt;13,002,242&lt;/span&gt; in cash on hand and $&lt;span id="xdx_908_ecustom--WorkingCapital_iI_c20260630_zSN1WWxOm5Zc" title="Working capital"&gt;12,052,688&lt;/span&gt; in working capital and believes that it will be sufficient to meet its planned
expenditures and to meet obligations for the&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;foreseeable
future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FMTOF:DisclosureOfNatureOfOperationsAndGoingConcernExplanatory>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-03-29_custom_BeyondSolutionLtdMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact000544"
      unitRef="Pure">0.74</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-03-29_custom_FormerShareholderMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact000546"
      unitRef="Pure">0.26</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2022-09-22_custom_ZigiCarmelInitiativesAndInvestmentsLtdMember_custom_FormerShareholderMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact000548"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="AsOf2022-09-22_custom_ZigiCarmelInitiativesAndInvestmentsLtdMember_custom_FormerShareholderMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact000550"
      unitRef="Shares">7920000</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="AsOf2022-09-22_custom_ZigiCarmelInitiativesAndInvestmentsLtdMember_custom_FormerShareholderMember_custom_ShareExchangeAgreementMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000552"
      unitRef="Shares">2452</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <FMTOF:StockholdersEquityReverseStockSplitDescription contextRef="From2025-04-172025-04-17" id="Fact000554">one (1) for five hundreds (500) reverse stock split</FMTOF:StockholdersEquityReverseStockSplitDescription>
    <ifrs-full:ProfitLoss
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000556"
      unitRef="CAD">-1749549</ifrs-full:ProfitLoss>
    <ifrs-full:CashFlowsFromUsedInOperations
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000558"
      unitRef="CAD">-1898279</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000560"
      unitRef="CAD">-61729681</ifrs-full:RetainedEarnings>
    <FMTOF:PrefundedAndInvestorWarrantsPricePerShare
      contextRef="From2025-02-282025-02-28"
      decimals="INF"
      id="Fact000562"
      unitRef="USDPShares">4.17</FMTOF:PrefundedAndInvestorWarrantsPricePerShare>
    <FMTOF:PurchaseAndSaleOfInstitutionalInvestors
      contextRef="From2025-02-282025-02-28"
      decimals="-5"
      id="Fact000564"
      unitRef="USD">17000000.0</FMTOF:PurchaseAndSaleOfInstitutionalInvestors>
    <FMTOF:PurchaseAndSaleOfInstitutionalInvestors
      contextRef="From2025-02-282025-02-28"
      decimals="0"
      id="Fact000566"
      unitRef="CAD">20552190</FMTOF:PurchaseAndSaleOfInstitutionalInvestors>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000568"
      unitRef="CAD">13002242</ifrs-full:CashAndCashEquivalents>
    <FMTOF:WorkingCapital
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000570"
      unitRef="CAD">12052688</FMTOF:WorkingCapital>
    <ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000572">&lt;p id="xdx_80F_eifrs-full--DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory_z03CzgyPNn97" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; &lt;span id="xdx_825_zssRk1py9DM6"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES AND JUDGMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zUSDh7LX9wB1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zBqv67Jh6gwg"&gt;Basis
    of presentation and statement of compliance&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards
(&#x201c;IFRS&#x201d;) as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;) and interpretations of the International
Financial Reporting Issues Committee (&#x201c;IFRIC&#x201d;) applicable to the preparation of interim financial statements, including International
Accounting Standard (&#x201c;IAS&#x201d;) 34 Interim Financial Reporting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES AND JUDGMENTS (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
notes presented in these condensed consolidated interim financial statements include only significant events and transactions occurring
since the Company&#x2019;s last fiscal year end and they do not include all of the information required in the Company&#x2019;s most recent
annual consolidated financial statements. Except as noted below, these condensed consolidated interim financial statements follow the
same accounting policies and methods of application as the Company&#x2019;s annual financial statements and should be read in conjunction
with the Company&#x2019;s annual financial statements for the year ended December 31, 2025, which were prepared in accordance with IFRS
as issued by IASB. There have been no significant changes in judgement or estimates from those disclosed in the consolidated financial
statements for the year ended December 31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eifrs-full--DisclosureOfBasisOfConsolidationExplanatory_zpiUyrT4nsOb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zjiCotVNQIW4"&gt;Basis
    of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
condensed consolidated interim financial statements incorporate the financial statements of the Company and of its wholly owned subsidiaries,
BYND, Zigi Carmel and B.Y.B.Y.. B.Y.B.Y is owned directly through BYND and &lt;span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20260630__ifrs-full--BusinessCombinationsAxis__custom--BeyondSolutionLtdMember__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--TypesOfContractsAxis__custom--ShareExchangeAgreementMember_zhb7sb05qfI4" title="Ownership interest"&gt;24&lt;/span&gt;% of the shares of B.Y.B.Y. are held by a related party
in trust for the Company for the purpose to comply with Israeli Cannabis Laws regarding the ownership of medical cannabis license rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
subsidiary is an entity over which the Company has control, directly or indirectly, where control is defined as the power to govern the
financial and operating policies of an enterprise so as to obtain benefits from its activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
subsidiary is consolidated from the date upon which control is acquired by the Company and all intercompany transactions and balances
have been eliminated on consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eifrs-full--DisclosureOfAuthorisationOfFinancialStatementsExplanatory_zVIgq4W9o46b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zgxfrSLIcr92"&gt;Basis
    of Measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
condensed consolidated interim financial statements were prepared based on the historical costs, except for financial instruments classified
as fair value through profit and loss (&#x201c;FVTPL&#x201d;) and assets or liabilities for employee benefits, which are stated at their
fair value. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_z5ImcNT7njI5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zz1pHcO13sOe"&gt;Currency
    of Operation and Currency of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
condensed consolidated interim financial statements are presented in Canadian dollars. The functional currency of the Company is US dollars,
and the functional currency of its subsidiaries is the New Israeli Shekel (&#x201c;NIS&#x201d;). NIS represents the main economic environment
in which the subsidiaries operate.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_z74BDMlNvPn1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zV50j4v2uCB"&gt;Significant
    estimates and assumptions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of these condensed consolidated interim financial statements in accordance with IFRS requires the Company to use judgment
in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the financial statements
and in the future. The Company&#x2019;s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience
and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates
are adjusted for prospectively in the period in which the estimates are revised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES AND JUDGMENTS (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
    estimates and assumptions (continued)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Income
taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provisions
for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant
factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible
that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related
matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in
which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their
recovery from the generation of taxable income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Useful
lives of property and equipment&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimates
of the useful lives of property and equipment are based on the period over which the assets are expected to be available for use. The
estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and
tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation
of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible,
however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors
mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances.
A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
debentures&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
identification of convertible note components is based on interpretations of the substance of the contractual arrangement and therefore
requires judgement from management. The separation of the components affects the initial recognition of the convertible debenture at
issuance and the subsequent recognition of interest on the liability component. The determination of the fair value of the liability
is also based on a number of assumptions, including contractual future cash flows, discount rates and the presence of any derivative
financial instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
Significant Judgments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates,
in applying accounting policies. The most significant judgments in applying the Company&#x2019;s financial statements include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    assessment of the Company&#x2019;s ability to continue as a going concern and whether there are events or conditions that may give
    rise to significant uncertainty;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES AND JUDGMENTS (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
    estimates and assumptions (continued)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    classification of financial instruments;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    determination of the functional currency of the company.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_855_zOIHWmdpgqy5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000574">&lt;p id="xdx_840_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zUSDh7LX9wB1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zBqv67Jh6gwg"&gt;Basis
    of presentation and statement of compliance&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards
(&#x201c;IFRS&#x201d;) as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;) and interpretations of the International
Financial Reporting Issues Committee (&#x201c;IFRIC&#x201d;) applicable to the preparation of interim financial statements, including International
Accounting Standard (&#x201c;IAS&#x201d;) 34 Interim Financial Reporting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES AND JUDGMENTS (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
notes presented in these condensed consolidated interim financial statements include only significant events and transactions occurring
since the Company&#x2019;s last fiscal year end and they do not include all of the information required in the Company&#x2019;s most recent
annual consolidated financial statements. Except as noted below, these condensed consolidated interim financial statements follow the
same accounting policies and methods of application as the Company&#x2019;s annual financial statements and should be read in conjunction
with the Company&#x2019;s annual financial statements for the year ended December 31, 2025, which were prepared in accordance with IFRS
as issued by IASB. There have been no significant changes in judgement or estimates from those disclosed in the consolidated financial
statements for the year ended December 31, 2025.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfBasisOfConsolidationExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000576">&lt;p id="xdx_841_eifrs-full--DisclosureOfBasisOfConsolidationExplanatory_zpiUyrT4nsOb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zjiCotVNQIW4"&gt;Basis
    of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
condensed consolidated interim financial statements incorporate the financial statements of the Company and of its wholly owned subsidiaries,
BYND, Zigi Carmel and B.Y.B.Y.. B.Y.B.Y is owned directly through BYND and &lt;span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20260630__ifrs-full--BusinessCombinationsAxis__custom--BeyondSolutionLtdMember__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember__ifrs-full--TypesOfContractsAxis__custom--ShareExchangeAgreementMember_zhb7sb05qfI4" title="Ownership interest"&gt;24&lt;/span&gt;% of the shares of B.Y.B.Y. are held by a related party
in trust for the Company for the purpose to comply with Israeli Cannabis Laws regarding the ownership of medical cannabis license rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -28.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
subsidiary is an entity over which the Company has control, directly or indirectly, where control is defined as the power to govern the
financial and operating policies of an enterprise so as to obtain benefits from its activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
subsidiary is consolidated from the date upon which control is acquired by the Company and all intercompany transactions and balances
have been eliminated on consolidation.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfBasisOfConsolidationExplanatory>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2026-06-30_custom_BeyondSolutionLtdMember_ifrs-full_RelatedPartiesMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact000578"
      unitRef="Pure">0.24</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000580">&lt;p id="xdx_84E_eifrs-full--DisclosureOfAuthorisationOfFinancialStatementsExplanatory_zVIgq4W9o46b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zgxfrSLIcr92"&gt;Basis
    of Measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
condensed consolidated interim financial statements were prepared based on the historical costs, except for financial instruments classified
as fair value through profit and loss (&#x201c;FVTPL&#x201d;) and assets or liabilities for employee benefits, which are stated at their
fair value. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000582">&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_z5ImcNT7njI5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zz1pHcO13sOe"&gt;Currency
    of Operation and Currency of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
condensed consolidated interim financial statements are presented in Canadian dollars. The functional currency of the Company is US dollars,
and the functional currency of its subsidiaries is the New Israeli Shekel (&#x201c;NIS&#x201d;). NIS represents the main economic environment
in which the subsidiaries operate.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000584">&lt;p id="xdx_84F_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_z74BDMlNvPn1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zV50j4v2uCB"&gt;Significant
    estimates and assumptions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of these condensed consolidated interim financial statements in accordance with IFRS requires the Company to use judgment
in applying its accounting policies and make estimates and assumptions about reported amounts at the date of the financial statements
and in the future. The Company&#x2019;s management reviews these estimates and underlying assumptions on an ongoing basis, based on experience
and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates
are adjusted for prospectively in the period in which the estimates are revised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES AND JUDGMENTS (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
    estimates and assumptions (continued)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Income
taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provisions
for income taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant
factors. The Company reviews the adequacy of these income tax provisions at the end of each reporting period. However, it is possible
that at some future date an additional liability could result from audits by tax authorities. Where the final outcome of these tax-related
matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in
which such determination is made. Deferred tax assets are recognized when it is determined that the company is likely to recognize their
recovery from the generation of taxable income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Useful
lives of property and equipment&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimates
of the useful lives of property and equipment are based on the period over which the assets are expected to be available for use. The
estimated useful lives are reviewed annually and are updated if expectations differ from previous estimates due to physical wear and
tear, technical or commercial obsolescence, and legal or other limits on the use of the relevant assets. In addition, the estimation
of the useful lives of the relevant assets may be based on internal technical evaluation and experience with similar assets. It is possible,
however, that future results of operations could be materially affected by changes in the estimates brought about by changes in the factors
mentioned above. The amounts and timing of recorded expenses for any period would be affected by changes in these factors and circumstances.
A reduction in the estimated useful lives of the equipment would increase the recorded expenses and decrease the non-current assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
debentures&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
identification of convertible note components is based on interpretations of the substance of the contractual arrangement and therefore
requires judgement from management. The separation of the components affects the initial recognition of the convertible debenture at
issuance and the subsequent recognition of interest on the liability component. The determination of the fair value of the liability
is also based on a number of assumptions, including contractual future cash flows, discount rates and the presence of any derivative
financial instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
Significant Judgments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in accordance with IFRS requires the Company to make judgments, apart from those involving estimates,
in applying accounting policies. The most significant judgments in applying the Company&#x2019;s financial statements include:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    assessment of the Company&#x2019;s ability to continue as a going concern and whether there are events or conditions that may give
    rise to significant uncertainty;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES AND JUDGMENTS (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Significant
    estimates and assumptions (continued)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; width: 0.25in; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    classification of financial instruments;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    assessment of revenue recognition using the five-step approach under IFRS 15 and the collectability of amounts receivable; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; text-align: justify; padding-bottom: 0pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
    determination of the functional currency of the company.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000586">&lt;p id="xdx_800_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zYHmfQeNumxc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_827_zpD2kgynypEi"&gt;OTHER RECEIVABLES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--DisclosureOfOtherReceivableExplanatory_z8V6DyojjvKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zi6utcfxl0ga" style="display: none"&gt;SCHEDULE OF OTHER RECEIVABLE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260630_zazaEWnQt2V1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zKUGz4H1zwPh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IncomeTaxAdvancesCurrent_iI_maTRzIgy_zQgAUNrBF47c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Income tax advances&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;11,102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;26,764&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentInterestReceivable_iI_maTRzIgy_zabDpBqX5Aq5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Interest receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;142,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;500,927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherCurrentReceivablesDueFromRelatedParties_iI_maTRzIgy_zMstf0PVxgf3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Due from shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,243&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--OtherReceivables_iTI_mtTRzIgy_zEI3fPDKy7Qd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;154,507&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;528,991&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_z7ZoS4o8Y7Hj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <FMTOF:DisclosureOfOtherReceivableExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000588">&lt;p id="xdx_893_ecustom--DisclosureOfOtherReceivableExplanatory_z8V6DyojjvKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zi6utcfxl0ga" style="display: none"&gt;SCHEDULE OF OTHER RECEIVABLE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260630_zazaEWnQt2V1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zKUGz4H1zwPh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IncomeTaxAdvancesCurrent_iI_maTRzIgy_zQgAUNrBF47c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Income tax advances&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;11,102&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;26,764&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentInterestReceivable_iI_maTRzIgy_zabDpBqX5Aq5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Interest receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;142,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;500,927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherCurrentReceivablesDueFromRelatedParties_iI_maTRzIgy_zMstf0PVxgf3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Due from shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,243&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--OtherReceivables_iTI_mtTRzIgy_zEI3fPDKy7Qd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;154,507&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;528,991&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FMTOF:DisclosureOfOtherReceivableExplanatory>
    <FMTOF:IncomeTaxAdvancesCurrent
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000590"
      unitRef="CAD">11102</FMTOF:IncomeTaxAdvancesCurrent>
    <FMTOF:IncomeTaxAdvancesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000591"
      unitRef="CAD">26764</FMTOF:IncomeTaxAdvancesCurrent>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000593"
      unitRef="CAD">142162</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000594"
      unitRef="CAD">500927</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000596"
      unitRef="CAD">1243</ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000597"
      unitRef="CAD">1300</ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000599"
      unitRef="CAD">154507</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000600"
      unitRef="CAD">528991</ifrs-full:OtherReceivables>
    <ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000602">&lt;p id="xdx_805_eifrs-full--DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_zGq7tuqgUtz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 &#x2013; &lt;span id="xdx_826_z1LkpXYfFps9"&gt;EQUITY METHOD INVESTMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2026, the Company entered into a share purchase agreement (the &#x201c;Share Purchase Agreement&#x201d;) with Gilad R.G. Planning
and Implementation of Technologies and Software 2025 Ltd. (&#x201c;Gilad&#x201d;) and its shareholder (the &#x201c;Vendor&#x201d;), to acquire
an equity interest in Gilad (the &#x201c;Acquisition&#x201d;) in order to strengthen the field of software services provided by Femto through
its subsidiary, BYND &#x2013; Beyond Solutions Ltd., and in order to remain relevant in light of the significant changes that the software
field is undergoing due to the prevalence of artificial intelligence engines.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Acquisition, Femto acquired:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.
from Gilad, &lt;span id="xdx_90C_ecustom--NumberOfPreviouslyUnissuedCommonShares_pid_uShares_c20260327__20260327__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_zSYeQw0VMSs8" title="Number of previously unissued common shares"&gt;43&lt;/span&gt; previously unissued common shares of Gilad (the &#x201c;Gilad Shares&#x201d;) for a total purchase price of US$&lt;span id="xdx_908_ecustom--EquityMethodInvestment_iI_uUSD_c20260327__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_z79ZjfVieBLb" title="Total purchase price"&gt;1,000,000&lt;/span&gt;
which will be used to complete development and sales in accordance with a budget to be approved by the parties (the &#x201c;Treasury Shares
Purchase Price&#x201d;), to be paid in four equal quarterly instalments of US$&lt;span id="xdx_909_ecustom--EquityMethodInvestment_iI_uUSD_c20260327__ifrs-full--MeasurementAxis__custom--FourEqualQuarterlyInstalmentsMember__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_zJ1Br6SMxmCk" title="Total purchase price"&gt;250,000&lt;/span&gt;; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.
from the Vendor, &lt;span id="xdx_900_ecustom--NumberOfSharesInConsideration_pid_uShares_c20260327__20260327__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_zD1DnwjuCxWc" title="Number of shares in consideration"&gt;14 &lt;/span&gt;Gilad Shares in consideration for:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.
the payment to the Vendor of the sum of US$&lt;span id="xdx_90E_ecustom--PaymentsToVendor_uUSD_c20260327__20260327__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_zLe0Dbypkdif" title="Payment to vendor"&gt;250,000&lt;/span&gt;; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.
the issuance to the Vendor of &lt;span id="xdx_902_ecustom--SharesIssuedEnhancedVotingPreferenceShares_uShares_c20260327__20260327__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_zRNaa3gV0O53" title="Subordinate voting shares"&gt;169,811&lt;/span&gt; subordinate voting shares in the capital of Femto (the &#x201c;Subordinate Voting Shares&#x201d;)
at deemed price of US$&lt;span id="xdx_90A_ecustom--PreferenceSharesVotesPerShare_iI_pid_c20260327__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_z4ji2jx6s7ph" title="Subordinate voting per share"&gt;0.589&lt;/span&gt; per Subordinate Voting Share (the &#x201c;Payment Shares&#x201d;), being the volume weighted daily average
market price of the Subordinate Voting Shares for the 30 trading days preceding the date of the Share Purchase Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
closing of the Acquisition on March 30, 2026, (the &#x201c;Closing&#x201d;), Femto held &lt;span id="xdx_905_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20260330__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_ztMzzYaLMmr2" title="Acquired percentage"&gt;40&lt;/span&gt;% of the issued and outstanding Gilad Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has determined that it has significant influence over Gilad and accordingly accounts for its investment under the equity method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2026, the company owes US$&lt;span id="xdx_900_ecustom--EquityMethodInvestment_iI_uUSD_c20260630__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_zqXpYyKZ6WL1" title="Total purchase price"&gt;750,000&lt;/span&gt; to Gilad (three quarterly instalments of US$&lt;span id="xdx_90B_ecustom--EquityMethodInvestment_iI_uUSD_c20260630__ifrs-full--MeasurementAxis__custom--ThreerEqualQuarterlyInstalmentsMember__ifrs-full--BusinessCombinationsAxis__custom--GiladMember_zhoJGXdfW4w8" title="Total purchase price"&gt;250,000&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory>
    <FMTOF:NumberOfPreviouslyUnissuedCommonShares
      contextRef="From2026-03-272026-03-27_custom_GiladMember"
      decimals="INF"
      id="Fact000604"
      unitRef="Shares">43</FMTOF:NumberOfPreviouslyUnissuedCommonShares>
    <FMTOF:EquityMethodInvestment
      contextRef="AsOf2026-03-27_custom_GiladMember"
      decimals="0"
      id="Fact000606"
      unitRef="USD">1000000</FMTOF:EquityMethodInvestment>
    <FMTOF:EquityMethodInvestment
      contextRef="AsOf2026-03-27_custom_FourEqualQuarterlyInstalmentsMember_custom_GiladMember"
      decimals="0"
      id="Fact000608"
      unitRef="USD">250000</FMTOF:EquityMethodInvestment>
    <FMTOF:NumberOfSharesInConsideration
      contextRef="From2026-03-272026-03-27_custom_GiladMember"
      decimals="INF"
      id="Fact000610"
      unitRef="Shares">14</FMTOF:NumberOfSharesInConsideration>
    <FMTOF:PaymentsToVendor
      contextRef="From2026-03-272026-03-27_custom_GiladMember"
      decimals="0"
      id="Fact000612"
      unitRef="USD">250000</FMTOF:PaymentsToVendor>
    <FMTOF:SharesIssuedEnhancedVotingPreferenceShares
      contextRef="From2026-03-272026-03-27_custom_GiladMember"
      decimals="INF"
      id="Fact000614"
      unitRef="Shares">169811</FMTOF:SharesIssuedEnhancedVotingPreferenceShares>
    <FMTOF:PreferenceSharesVotesPerShare
      contextRef="AsOf2026-03-27_custom_GiladMember"
      decimals="INF"
      id="Fact000616"
      unitRef="CADPShares">0.589</FMTOF:PreferenceSharesVotesPerShare>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2026-03-30_custom_GiladMember"
      decimals="INF"
      id="Fact000618"
      unitRef="Pure">0.40</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <FMTOF:EquityMethodInvestment
      contextRef="AsOf2026-06-30_custom_GiladMember"
      decimals="0"
      id="Fact000620"
      unitRef="USD">750000</FMTOF:EquityMethodInvestment>
    <FMTOF:EquityMethodInvestment
      contextRef="AsOf2026-06-30_custom_ThreerEqualQuarterlyInstalmentsMember_custom_GiladMember"
      decimals="0"
      id="Fact000622"
      unitRef="USD">250000</FMTOF:EquityMethodInvestment>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000624">&lt;p id="xdx_801_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zCLfPOjSyGPi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 &#x2013; &lt;span id="xdx_828_zZpnAW6w9Sjd"&gt;INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s intangible assets relate to 2 patents pending for the Sensera device.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Patents include the fair value attributed to the Patents upon the acquisition of ZC of $&lt;span id="xdx_90A_ecustom--Patents_uCAD_c20260101__20260630_zGpYPLlQ0fKg" title="Patents"&gt;42,768,000&lt;/span&gt; as well as transaction and other costs
in the amount of $&lt;span id="xdx_90A_eifrs-full--OtherIntangibleAssets_iI_uCAD_c20260630_z2TYwPtYzfvl" title="Other costs"&gt;193,382&lt;/span&gt;, for a total of $&lt;span id="xdx_907_ecustom--TransactionAndOtherCostsNet_iI_uCAD_c20260630_zcfE8kNb47M3" title="Transaction and other costs, net"&gt;42,961,382&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considered indicators of impairment at December 31, 2025. The Company recorded impairment loss during the year ended December
31, 2025, for the patents pending since the recoverable amount is lower than the carrying amount. The recoverable amount of the CGU was
determined using fair value less costs to sell based on a third-party valuation. The valuation used a market approach with Level 2 inputs,
including recent comparable transactions and observable market data. Costs of disposal were estimated at &lt;span id="xdx_90C_ecustom--PercentageOfFairValueOfCostOfDisposal_pid_dp_uPure_c20260101__20260630_zh5N92XrX6dc" title="Fair value of cost of disposal, percentage"&gt;2&lt;/span&gt;% of fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zFXZYRwhCZxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zcIcZNbS3YQk" style="display: none"&gt;SCHEDULE OF PATENTS INCLUDE THE FAIR VALUE ATTRIBUTED TO THE PATENTS UPON THE ACQUISITION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Software&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Patents Pending&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; padding-left: 0pt"&gt;Balance, December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_z5z02gAa6tE1" style="width: 14%; text-align: right" title="Cost, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_z3LTP4iwPyhd" style="width: 14%; text-align: right" title="Cost, beginning balance"&gt;25,262,767&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zY42p9Tiq4K7" style="width: 14%; text-align: right" title="Cost, beginning balance"&gt;25,344,005&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zkPvAV3U9XB6" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zcf01sVUh7zk" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkr8RLtQreU1" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0646"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ImpairmentLossRecognisedInProfitOrLossImpairments_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zAThqHftE9mh" style="text-align: right" title="Impairments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0648"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ImpairmentLossRecognisedInProfitOrLossImpairments_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zr8NWaqZ46M5" style="text-align: right" title="Impairments"&gt;(5,462,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ImpairmentLossRecognisedInProfitOrLossImpairments_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjD50H9rXXxc" style="text-align: right" title="Impairments"&gt;(5,462,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Translation differences&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zq0sHSyUM8L6" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zaQ0b5Va6Zz5" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0656"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZAuCDknvPj2" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Balance, December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zoNeW9VMOp17" style="text-align: right" title="Cost, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zTgqyzj3Xbp2" style="text-align: right" title="Cost, beginning balance"&gt;19,800,767&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1VheCFXcODc" style="text-align: right" title="Cost, beginning balance"&gt;19,882,005&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_znVpDynGbE93" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zSygTMrx4ml" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0668"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zr5mKMOD1of5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0670"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Translation differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zzYrbszdCBOg" style="text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0672"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zJhWmVtcWknl" style="text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7DPnEXmcnod" style="text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0676"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;Balance, June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zGOFIIlXskm9" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, ending balance"&gt;81,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zTANyZPlTxnh" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, beginning balance"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgXmHvlpNGy1" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, ending balance"&gt;19,882,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Balance, December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_z1H1YyotgvD2" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_z0iwBrO9Jge1" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0686"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z11edHe9Zn5g" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zUnhhCynNln4" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zJbrQQeBHLzl" style="text-align: right" title="Accumulated amortization, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrFD8esQ69Oc" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0694"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Translation differences&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_z57jNzkf7ARk" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zXUwnzFSBSX1" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJMkkHnbKTig" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0700"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Balance, December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_ztHAWLPj9QFb" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zCqXLfsIIaHi" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4gZOo5m4rfi" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zUInlsAQhfDl" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zbc8T66eM2M9" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0710"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGU8MbEV4tgl" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0712"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;Balance, June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccumulatedAmortizationIntellectualProperties_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zbJrsdQ1hWxg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation, ending balance"&gt;81,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccumulatedAmortizationIntellectualProperties_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_z7Js0b5j1ue5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0716"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQXAO6501Gzb" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-left: 0pt"&gt;Net book value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zQYivNGMUOs7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0720"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zoS0TBqBIhEi" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcqnjc2JMUnd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At June 30, 2026&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zUtv0zN2HiQi" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0726"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zDVIIXnX9r84" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf8F2u7SgX6f" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zv2ktDtPzts9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <FMTOF:Patents
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000626"
      unitRef="CAD">42768000</FMTOF:Patents>
    <ifrs-full:OtherIntangibleAssets
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000628"
      unitRef="CAD">193382</ifrs-full:OtherIntangibleAssets>
    <FMTOF:TransactionAndOtherCostsNet
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000630"
      unitRef="CAD">42961382</FMTOF:TransactionAndOtherCostsNet>
    <FMTOF:PercentageOfFairValueOfCostOfDisposal
      contextRef="From2026-01-01to2026-06-30"
      decimals="INF"
      id="Fact000632"
      unitRef="Pure">0.02</FMTOF:PercentageOfFairValueOfCostOfDisposal>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000634">&lt;p id="xdx_899_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zFXZYRwhCZxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zcIcZNbS3YQk" style="display: none"&gt;SCHEDULE OF PATENTS INCLUDE THE FAIR VALUE ATTRIBUTED TO THE PATENTS UPON THE ACQUISITION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Software&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Patents Pending&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; padding-left: 0pt"&gt;Balance, December 31, 2024&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_z5z02gAa6tE1" style="width: 14%; text-align: right" title="Cost, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_z3LTP4iwPyhd" style="width: 14%; text-align: right" title="Cost, beginning balance"&gt;25,262,767&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zY42p9Tiq4K7" style="width: 14%; text-align: right" title="Cost, beginning balance"&gt;25,344,005&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zkPvAV3U9XB6" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zcf01sVUh7zk" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkr8RLtQreU1" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0646"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ImpairmentLossRecognisedInProfitOrLossImpairments_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zAThqHftE9mh" style="text-align: right" title="Impairments"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0648"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ImpairmentLossRecognisedInProfitOrLossImpairments_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zr8NWaqZ46M5" style="text-align: right" title="Impairments"&gt;(5,462,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ImpairmentLossRecognisedInProfitOrLossImpairments_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjD50H9rXXxc" style="text-align: right" title="Impairments"&gt;(5,462,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Translation differences&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zq0sHSyUM8L6" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zaQ0b5Va6Zz5" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0656"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZAuCDknvPj2" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Balance, December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zoNeW9VMOp17" style="text-align: right" title="Cost, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zTgqyzj3Xbp2" style="text-align: right" title="Cost, beginning balance"&gt;19,800,767&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1VheCFXcODc" style="text-align: right" title="Cost, beginning balance"&gt;19,882,005&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_znVpDynGbE93" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zSygTMrx4ml" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0668"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ImpairmentLossRecognisedInProfitOrLossAdditions_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zr5mKMOD1of5" style="text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0670"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Translation differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zzYrbszdCBOg" style="text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0672"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zJhWmVtcWknl" style="text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntangibleAssetsOtherThanGoodwillGrossTranslationDifferences_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7DPnEXmcnod" style="text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0676"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;Balance, June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zGOFIIlXskm9" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, ending balance"&gt;81,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zTANyZPlTxnh" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, beginning balance"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgXmHvlpNGy1" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, ending balance"&gt;19,882,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Balance, December 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_z1H1YyotgvD2" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_z0iwBrO9Jge1" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0686"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z11edHe9Zn5g" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zUnhhCynNln4" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zJbrQQeBHLzl" style="text-align: right" title="Accumulated amortization, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrFD8esQ69Oc" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0694"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Translation differences&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_z57jNzkf7ARk" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zXUwnzFSBSX1" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccumulatedAmortizationIntellectualPropertiesOfTranslationDifferences_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zJMkkHnbKTig" style="border-bottom: Black 1pt solid; text-align: right" title="Translation differences"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0700"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0pt"&gt;Balance, December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_ztHAWLPj9QFb" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zCqXLfsIIaHi" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z4gZOo5m4rfi" style="text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zUInlsAQhfDl" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zbc8T66eM2M9" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0710"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccumulatedAmortizationIntellectualPropertiesOfDepreciation_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGU8MbEV4tgl" style="text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0712"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;Balance, June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccumulatedAmortizationIntellectualProperties_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zbJrsdQ1hWxg" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation, ending balance"&gt;81,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccumulatedAmortizationIntellectualProperties_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_z7Js0b5j1ue5" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0716"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccumulatedAmortizationIntellectualProperties_iS_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQXAO6501Gzb" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation, beginning balance"&gt;81,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-left: 0pt"&gt;Net book value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zQYivNGMUOs7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0720"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zoS0TBqBIhEi" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20250101__20251231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcqnjc2JMUnd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At June 30, 2026&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerSoftwareMember_zUtv0zN2HiQi" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0726"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PatentMember_zDVIIXnX9r84" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntangibleAssetsExcludingGoodwill_iE_c20260101__20260630__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf8F2u7SgX6f" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Intangible assets, net book value"&gt;19,800,767&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      decimals="0"
      id="Fact000636"
      unitRef="CAD">81238</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      decimals="0"
      id="Fact000638"
      unitRef="CAD">25262767</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000640"
      unitRef="CAD">25344005</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossImpairments
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      decimals="0"
      id="Fact000650"
      unitRef="CAD">-5462000</FMTOF:ImpairmentLossRecognisedInProfitOrLossImpairments>
    <FMTOF:ImpairmentLossRecognisedInProfitOrLossImpairments
      contextRef="From2025-01-012025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000652"
      unitRef="CAD">-5462000</FMTOF:ImpairmentLossRecognisedInProfitOrLossImpairments>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      decimals="0"
      id="Fact000660"
      unitRef="CAD">81238</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      decimals="0"
      id="Fact000662"
      unitRef="CAD">19800767</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000664"
      unitRef="CAD">19882005</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      decimals="0"
      id="Fact000678"
      unitRef="CAD">81238</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      decimals="0"
      id="Fact000680"
      unitRef="CAD">19800767</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:IntangibleAssetsOtherThanGoodwillGross
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000682"
      unitRef="CAD">19882005</FMTOF:IntangibleAssetsOtherThanGoodwillGross>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      decimals="0"
      id="Fact000684"
      unitRef="CAD">81238</FMTOF:AccumulatedAmortizationIntellectualProperties>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2024-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000688"
      unitRef="CAD">81238</FMTOF:AccumulatedAmortizationIntellectualProperties>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      decimals="0"
      id="Fact000702"
      unitRef="CAD">81238</FMTOF:AccumulatedAmortizationIntellectualProperties>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000706"
      unitRef="CAD">81238</FMTOF:AccumulatedAmortizationIntellectualProperties>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"
      decimals="0"
      id="Fact000714"
      unitRef="CAD">81238</FMTOF:AccumulatedAmortizationIntellectualProperties>
    <FMTOF:AccumulatedAmortizationIntellectualProperties
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000718"
      unitRef="CAD">81238</FMTOF:AccumulatedAmortizationIntellectualProperties>
    <FMTOF:IntangibleAssetsExcludingGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      decimals="0"
      id="Fact000722"
      unitRef="CAD">19800767</FMTOF:IntangibleAssetsExcludingGoodwill>
    <FMTOF:IntangibleAssetsExcludingGoodwill
      contextRef="AsOf2025-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000724"
      unitRef="CAD">19800767</FMTOF:IntangibleAssetsExcludingGoodwill>
    <FMTOF:IntangibleAssetsExcludingGoodwill
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember_custom_PatentMember"
      decimals="0"
      id="Fact000728"
      unitRef="CAD">19800767</FMTOF:IntangibleAssetsExcludingGoodwill>
    <FMTOF:IntangibleAssetsExcludingGoodwill
      contextRef="AsOf2026-06-30_ifrs-full_GrossCarryingAmountMember"
      decimals="0"
      id="Fact000730"
      unitRef="CAD">19800767</FMTOF:IntangibleAssetsExcludingGoodwill>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000732">&lt;p id="xdx_806_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zECokNv4fkGk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_825_zvorgcgmzHvl"&gt;TRADE PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory_zIiHgnNCTFo6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_z9RJSzmAK7t7" style="display: none"&gt;SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20260630_z140hEZW7Cr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zkUtSq2GOyp7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_msTAOCPzC7E_maTAOPzIkD_zrndN4q6jDLa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Trades payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;18,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;226,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--CurrentValueAddedTaxPayables_iI_maTAOPzIkD_zobZPEBD7Tsk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;VAT, income and dividend taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_msTAOCPzC7E_maTAOPzIkD_ztptEzSo1w58" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Salaries payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;91,613&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;82,772&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherPayables_iTI_mtTAOPzIkD_zYTQNAxkutE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    payables and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;131,305&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;317,537&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zZDAUCQXdlTk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <FMTOF:DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000734">&lt;p id="xdx_897_ecustom--DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory_zIiHgnNCTFo6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_z9RJSzmAK7t7" style="display: none"&gt;SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20260630_z140hEZW7Cr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231_zkUtSq2GOyp7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_msTAOCPzC7E_maTAOPzIkD_zrndN4q6jDLa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Trades payables&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;18,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;226,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--CurrentValueAddedTaxPayables_iI_maTAOPzIkD_zobZPEBD7Tsk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;VAT, income and dividend taxes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_msTAOCPzC7E_maTAOPzIkD_ztptEzSo1w58" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Salaries payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;91,613&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;82,772&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--TradeAndOtherPayables_iTI_mtTAOPzIkD_zYTQNAxkutE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
    payables and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;131,305&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;317,537&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FMTOF:DisclosureOfDetailedInformationAboutPayablesAndAccruedLiabilitiesExplanatory>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000736"
      unitRef="CAD">18808</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000737"
      unitRef="CAD">226315</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:CurrentValueAddedTaxPayables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000739"
      unitRef="CAD">20884</ifrs-full:CurrentValueAddedTaxPayables>
    <ifrs-full:CurrentValueAddedTaxPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000740"
      unitRef="CAD">8450</ifrs-full:CurrentValueAddedTaxPayables>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000742"
      unitRef="CAD">91613</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000743"
      unitRef="CAD">82772</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000745"
      unitRef="CAD">131305</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000746"
      unitRef="CAD">317537</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000748">&lt;p id="xdx_80C_eifrs-full--DisclosureOfRelatedPartyExplanatory_zJCgAxIoUS2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7&#x2013; &lt;span id="xdx_82B_za9nWwTplPE9"&gt;RELATED PARTY TRANSACTIONS BALANCES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key
management personnel include those persons having authority and responsibility for planning, directing and controlling the activities
of the Company as a whole. The Company has determined that key management personnel consist of members of the Company&#x2019;s Board of
Directors and corporate officers. The remuneration of directors and key management personnel, not including normal employee compensation,
made during the six months ended June 30, 2026, and the six months ended June 30, 2025, is set out below:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zmGJI3jkrKvg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zTpL8vC9TIy2" style="display: none"&gt;SCHEDULE OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20260101__20260630_znvAdpLuv0v4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20250101__20250630_zFGpyIk64so8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--WagesAndSalaries_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__ifrs-full--CostOfSalesMember_zWHZVVM9exaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify; padding-left: 0pt"&gt;salary (cost of sales)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;56,937&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;66,916&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ServicesExpense_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentMember_zo9ZrZBPeIKc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;consulting (research and development)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,199&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--ProfessionalFeesExpense_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ProfessionalFeesMember_z0PlZM4zhvS" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;consulting (professional fees)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;116,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,637&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SharebasedPayments_zjDJweVh6tIf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;share based payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;71,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,004,876&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--WagesAndSalaries_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__ifrs-full--SellingGeneralAndAdministrativeExpenseMember_zxegHiWKt3G8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;salary (general and administrative expenses)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;783,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384,027&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--WagesAndSalaries_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__ifrs-full--SellingGeneralAndAdministrativeExpenseMember_zXPQZPpB2or3" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;salary&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;783,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384,027&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eifrs-full--EmployeeBenefitsExpense_iT_z6Aa4QZglkc9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,090,395&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,614,655&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zCFkMAjaTnGi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at June 30, 2026, $&lt;span id="xdx_902_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20260630_zy7nUODalrnc" title="Amounts owed recorded in other receivable"&gt;1,243&lt;/span&gt; was owed from shareholders of the company (December 31, 2025&#x2013; $&lt;span id="xdx_909_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20251231_zJBsVltpRx7e" title="Amounts owed recorded in other receivable"&gt;1,300&lt;/span&gt;). Amounts owed were recorded in accounts
receivable are non-interest bearing and unsecured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at June 30, 2026, $&lt;span id="xdx_905_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20260630_zm7R3Mt0r4a" title="Amounts owed recorded in accounts payable"&gt;151,910&lt;/span&gt; was owed to directors of the Company (December 31, 2025&#x2013; $&lt;span id="xdx_90D_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_c20251231_z2BkKFsanwv3" title="Amounts owed recorded in accounts payable"&gt;113,892&lt;/span&gt;). Amounts due are non-interest bearing
and unsecured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000750">&lt;p id="xdx_896_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zmGJI3jkrKvg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zTpL8vC9TIy2" style="display: none"&gt;SCHEDULE OF RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20260101__20260630_znvAdpLuv0v4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20250101__20250630_zFGpyIk64so8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--WagesAndSalaries_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__ifrs-full--CostOfSalesMember_zWHZVVM9exaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify; padding-left: 0pt"&gt;salary (cost of sales)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;56,937&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;66,916&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ServicesExpense_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentMember_zo9ZrZBPeIKc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;consulting (research and development)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,199&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--ProfessionalFeesExpense_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ProfessionalFeesMember_z0PlZM4zhvS" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;consulting (professional fees)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;116,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,637&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SharebasedPayments_zjDJweVh6tIf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;share based payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;71,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,004,876&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--WagesAndSalaries_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__ifrs-full--SellingGeneralAndAdministrativeExpenseMember_zxegHiWKt3G8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;salary (general and administrative expenses)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;783,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384,027&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--WagesAndSalaries_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__ifrs-full--SellingGeneralAndAdministrativeExpenseMember_zXPQZPpB2or3" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;salary&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;783,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,384,027&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eifrs-full--EmployeeBenefitsExpense_iT_z6Aa4QZglkc9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,090,395&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,614,655&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="From2026-01-012026-06-30_ifrs-full_CostOfSalesMember"
      decimals="0"
      id="Fact000752"
      unitRef="CAD">56937</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-01-012025-06-30_ifrs-full_CostOfSalesMember"
      decimals="0"
      id="Fact000753"
      unitRef="CAD">66916</ifrs-full:WagesAndSalaries>
    <ifrs-full:ServicesExpense
      contextRef="From2026-01-012026-06-30_custom_ResearchAndDevelopmentMember"
      decimals="0"
      id="Fact000755"
      unitRef="CAD">62262</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2025-01-012025-06-30_custom_ResearchAndDevelopmentMember"
      decimals="0"
      id="Fact000756"
      unitRef="CAD">63199</ifrs-full:ServicesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2026-01-012026-06-30_custom_ProfessionalFeesMember"
      decimals="0"
      id="Fact000758"
      unitRef="CAD">116222</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-01-012025-06-30_custom_ProfessionalFeesMember"
      decimals="0"
      id="Fact000759"
      unitRef="CAD">95637</ifrs-full:ProfessionalFeesExpense>
    <FMTOF:SharebasedPayments
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000761"
      unitRef="CAD">71604</FMTOF:SharebasedPayments>
    <FMTOF:SharebasedPayments
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000762"
      unitRef="CAD">2004876</FMTOF:SharebasedPayments>
    <ifrs-full:WagesAndSalaries
      contextRef="From2026-01-012026-06-30_ifrs-full_SellingGeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact000764"
      unitRef="CAD">783370</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-01-012025-06-30_ifrs-full_SellingGeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact000765"
      unitRef="CAD">1384027</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2026-01-012026-06-30_ifrs-full_SellingGeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact000767"
      unitRef="CAD">783370</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-01-012025-06-30_ifrs-full_SellingGeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact000768"
      unitRef="CAD">1384027</ifrs-full:WagesAndSalaries>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000770"
      unitRef="CAD">1090395</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000771"
      unitRef="CAD">3614655</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000773"
      unitRef="CAD">1243</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000775"
      unitRef="CAD">1300</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000777"
      unitRef="CAD">151910</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000779"
      unitRef="CAD">113892</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000781">&lt;p id="xdx_801_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z2q5fmOrAw7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2013; &lt;span id="xdx_82B_zL189fkSUNWc"&gt;SHARE CAPITAL&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Authorized&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unlimited
number of subordinate voting shares without par value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Issued&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at June 30, 2026, &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_c20260630__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember_zpVUu5JZlJFj" title="Number of shares issued"&gt;&lt;span id="xdx_901_eifrs-full--NumberOfSharesOutstanding_iI_c20260630__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember_z4t0uMa5A7R" title="Number of shares outstanding"&gt;1,037,774&lt;/span&gt;&lt;/span&gt; subordinate voting shares were issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;During
the six months ended June 30, 2026&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 30, 2026, the Company issued &lt;span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_c20260330__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--CounterpartiesAxis__custom--VendorMember_zcrLEvFrYXp7" title="Number of shares issued"&gt;169,811&lt;/span&gt; subordinate voting shares to the Vendor (See note 4)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 9, 2026, the Company issued &lt;span id="xdx_900_eifrs-full--NumberOfInstrumentsOrInterestsIssuedOrIssuable_iI_uShares_c20260409__ifrs-full--CounterpartiesAxis__custom--DirectorsMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--EventsAfterReportingPeriodMember_zxMso6CrhLwi" title="Number of shares issuance"&gt;6,852&lt;/span&gt; subordinate voting shares to directors of the Company following the vesting of RSU&#x2019;s.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2013; SHARE CAPITAL (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;During
the six months ended June 30, 2025&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 3, 2025, the Company issued &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_c20250103__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBWarrantsMember_zhWXclqkuoyi" title="Number of shares issued"&gt;2,767&lt;/span&gt; subordinate voting shares (&lt;span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_c20250103__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBWarrantsMember__ifrs-full--ReclassifiedItemsAxis__custom--PostReverseSplitMember_zgJlRjMFhhta" title="Number of shares issued"&gt;6&lt;/span&gt; subordinate voting shares post reverse split) following the exercise
of B warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 6, 2025, the Company issued &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20250106__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBWarrantsMember_zGzNZyZy8Dtd" title="Number of shares issued"&gt;8,808&lt;/span&gt; subordinate voting shares (&lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_c20250106__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBWarrantsMember__ifrs-full--ReclassifiedItemsAxis__custom--PostReverseSplitMember_zEStipuEBRy7" title="Number of shares issued"&gt;18&lt;/span&gt; subordinate voting shares post reverse split) following the exercise
of B warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 7, 2025, the Company issued &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20250207__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--CounterpartiesAxis__custom--DirectorsAndConsultantsMember_zJ5NNn5CjSV3" title="Number of shares issued"&gt;188,000&lt;/span&gt; subordinate voting shares &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20250207__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--CounterpartiesAxis__custom--DirectorsAndConsultantsMember__ifrs-full--ReclassifiedItemsAxis__custom--PostReverseSplitMember_z9yLyAmXlPOa" title="Number of shares issued"&gt;(376&lt;/span&gt; subordinate voting shares post reverse split) to directors
and consultants of the Company following the vesting of RSU&#x2019;s. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 25, 2025, the Company issued &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_c20250225__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBWarrantsMember_z3qWpYFSYdE1" title="Number of shares issued"&gt;4,000&lt;/span&gt; subordinate voting shares (&lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_c20250225__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBWarrantsMember__ifrs-full--ReclassifiedItemsAxis__custom--PostReverseSplitMember_zewwGYtHXFmb" title="Number of shares issued"&gt;8&lt;/span&gt; subordinate voting shares post reverse split) following the
exercise of B warrants and &lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_c20250225__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesAWarrantsMember_zxXG7fBBSSCf" title="Number of shares issued"&gt;2,462&lt;/span&gt; subordinate voting shares (&lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_c20250225__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesAWarrantsMember__ifrs-full--ReclassifiedItemsAxis__custom--PostReverseSplitMember_zYMqbwbS99y4" title="Number of shares issued"&gt;5&lt;/span&gt; subordinate voting shares post reverse split) following the exercise of
A warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2025, the Company announced the closing of a Private Placement with gross proceeds to the Company of approximately of $&lt;span id="xdx_90D_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20250228__20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember_zeesjB98hf78" title="Gross proceeds"&gt;24,544,583&lt;/span&gt;
before deducting Agent placement commission and other expenses paid by the Company in the amount of $&lt;span id="xdx_900_eifrs-full--ShareIssueRelatedCost_c20250228__20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember_ztxfDtkOfFs9" title="Share issuance expense"&gt;3,992,393&lt;/span&gt;, totaling in a net amount
of $&lt;span id="xdx_907_eifrs-full--ProceedsFromIssuingShares_c20250228__20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember_zWFXbZaaOBMb" title="Net proceeds"&gt;20,552,190&lt;/span&gt;. Pursuant to the Private Placement, The Company issued &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember_zTpdxhdF5TLi" title="Number of shares issued"&gt;2,065,120&lt;/span&gt; subordinate voting shares (&lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ReclassifiedItemsAxis__custom--PostReverseSplitMember_zYgJPUGcq2el" title="Number of shares issued"&gt;4,130&lt;/span&gt; subordinate voting shares
post reverse split), &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsMember_zPYNSAtZMor4" title="Number of shares issued"&gt;2,011,616&lt;/span&gt; Pre-Funded Warrants, &lt;span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesAWarrantsMember_z6z9QkytiVug" title="Number of shares issued"&gt;4,076,736&lt;/span&gt; series A warrants and &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250228__ifrs-full--TypesOfContractsAxis__custom--PrivatePlacementsMember__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--SeriesBWarrantsMember_zPDSzufEJhE8" title="Number of shares issued"&gt;4,076,736&lt;/span&gt; series B warrants. See note 10 for a discussion
of the terms of the series A and B warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 21, 2025, the Company issued &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_c20250421__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--CounterpartiesAxis__custom--DirectorsMember_zYBRcln8yBw6"&gt;7,710&lt;/span&gt; subordinate voting shares (&lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_c20250421__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--CounterpartiesAxis__custom--DirectorsMember__ifrs-full--ReclassifiedItemsAxis__custom--PostReverseSplitMember_z8bM3oCdoOS5"&gt;15&lt;/span&gt; subordinate voting shares post reverse split) to directors following
the vesting of RSU&#x2019;s.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 22, 2025, the Company issued &lt;span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_c20250422__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--CounterpartiesAxis__custom--CEOMember_zWE84Bp4l205" title="Number of shares issued"&gt;70,073&lt;/span&gt; subordinate voting shares to its C.E.O.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 25, 2025, the Company issued &lt;span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_c20250425__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--CounterpartiesAxis__custom--DirectorsAndConsultantsMember_zKLh6jZQLjXi"&gt;131,800&lt;/span&gt; subordinate voting shares to directors and consultants following the vesting of RSU&#x2019;s.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
April 10, 2025 and until April 24, 2025, the Company issued &lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_c20250424__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PreFundedWarrantsAndSeriesBWarrantsMember_zmLkv2t1Ubyd"&gt;652,767&lt;/span&gt; subordinate voting shares following the exercise of Pre-Funded Warrants
and Series B Warrants that were exercised in alternative cashless method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six-month period ended June 30, 2025, the Company repurchased &lt;span id="xdx_906_ecustom--NumberOfSharesRepurchased_pid_uShares_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember_z23fgc2dCCV" title="Number of shares repurchased"&gt;19,747&lt;/span&gt; subordinate voting shares for $&lt;span id="xdx_908_eifrs-full--IncreaseDecreaseThroughTreasuryShareTransactions_pid_c20250101__20250630__ifrs-full--ComponentsOfEquityAxis__custom--SubordinateVotingSharesMember_z9gVgdGhdaNj" title="Value of shares repurchased"&gt;127,785&lt;/span&gt; and returned them to
treasury.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a stock option plan to grant incentive stock options to directors, officers, employees and consultants. Under the plan, the
aggregate number of subordinate voting shares that may be subject to option at any one time may not exceed 30% of the issued subordinate
voting shares of the Company as of that date, including options granted prior to the adoption of the plan. The exercise price of these
options is not less than the Company&#x2019;s closing market price on the day prior to the grant of the options. Options granted &lt;span id="xdx_90D_eifrs-full--DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement_c20260101__20260630_zC351vWGYyBa" title="Options term description"&gt;may not
exceed a term of ten years&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2026, and 2025 there were &lt;span id="xdx_905_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_do_uShares_c20260630_zvW6iU5MMxNe" title="Number of options, outstanding"&gt;&lt;span id="xdx_908_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_do_uShares_c20250630_z6S6hd58OFU7" title="Number of options, outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; stock options outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-06-30_custom_SubordinateVotingSharesMember"
      decimals="INF"
      id="Fact000783"
      unitRef="Shares">1037774</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2026-06-30_custom_SubordinateVotingSharesMember"
      decimals="INF"
      id="Fact000785"
      unitRef="Shares">1037774</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-03-30_custom_SubordinateVotingSharesMember_custom_VendorMember"
      decimals="INF"
      id="Fact000787"
      unitRef="Shares">169811</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable
      contextRef="AsOf2026-04-09_custom_DirectorsMember_custom_EventsAfterReportingPeriodMember"
      decimals="INF"
      id="Fact000789"
      unitRef="Shares">6852</ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-03_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact000791"
      unitRef="Shares">2767</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-03_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000793"
      unitRef="Shares">6</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-06_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact000795"
      unitRef="Shares">8808</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-06_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000797"
      unitRef="Shares">18</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-07_custom_SubordinateVotingSharesMember_custom_DirectorsAndConsultantsMember"
      decimals="INF"
      id="Fact000799"
      unitRef="Shares">188000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-07_custom_SubordinateVotingSharesMember_custom_DirectorsAndConsultantsMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000801"
      unitRef="Shares">-376</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact000803"
      unitRef="Shares">4000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000805"
      unitRef="Shares">8</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact000807"
      unitRef="Shares">2462</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-25_custom_SubordinateVotingSharesMember_custom_SeriesAWarrantsMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000809"
      unitRef="Shares">5</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2025-02-282025-02-28_custom_PrivatePlacementsMember"
      decimals="0"
      id="Fact000811"
      unitRef="CAD">24544583</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-02-282025-02-28_custom_PrivatePlacementsMember"
      decimals="0"
      id="Fact000813"
      unitRef="CAD">3992393</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2025-02-282025-02-28_custom_PrivatePlacementsMember"
      decimals="0"
      id="Fact000815"
      unitRef="CAD">20552190</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember"
      decimals="INF"
      id="Fact000817"
      unitRef="Shares">2065120</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000819"
      unitRef="Shares">4130</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact000821"
      unitRef="Shares">2011616</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      id="Fact000823"
      unitRef="Shares">4076736</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-28_custom_PrivatePlacementsMember_custom_SubordinateVotingSharesMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      id="Fact000825"
      unitRef="Shares">4076736</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-04-21_custom_SubordinateVotingSharesMember_custom_DirectorsMember"
      decimals="INF"
      id="Fact000826"
      unitRef="Shares">7710</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-04-21_custom_SubordinateVotingSharesMember_custom_DirectorsMember_custom_PostReverseSplitMember"
      decimals="INF"
      id="Fact000827"
      unitRef="Shares">15</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-04-22_custom_SubordinateVotingSharesMember_custom_CEOMember"
      decimals="INF"
      id="Fact000829"
      unitRef="Shares">70073</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-04-25_custom_SubordinateVotingSharesMember_custom_DirectorsAndConsultantsMember"
      decimals="INF"
      id="Fact000830"
      unitRef="Shares">131800</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-04-24_custom_SubordinateVotingSharesMember_custom_PreFundedWarrantsAndSeriesBWarrantsMember"
      decimals="INF"
      id="Fact000831"
      unitRef="Shares">652767</ifrs-full:NumberOfSharesIssued>
    <FMTOF:NumberOfSharesRepurchased
      contextRef="From2025-01-012025-06-30_custom_SubordinateVotingSharesMember"
      decimals="INF"
      id="Fact000833"
      unitRef="Shares">19747</FMTOF:NumberOfSharesRepurchased>
    <ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions
      contextRef="From2025-01-012025-06-30_custom_SubordinateVotingSharesMember"
      decimals="INF"
      id="Fact000835"
      unitRef="CAD">127785</ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions>
    <ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement contextRef="From2026-01-01to2026-06-30" id="Fact000837">may not
exceed a term of ten years</ifrs-full:DescriptionOfMaximumTermOfOptionsGrantedForSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2026-06-30"
      decimals="INF"
      id="Fact000839"
      unitRef="Shares">0</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000841"
      unitRef="Shares">0</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:DisclosureOfRevenueExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000843">&lt;p id="xdx_805_eifrs-full--DisclosureOfRevenueExplanatory_zm4x29oIHSKd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2013; &lt;span id="xdx_82F_zmbPZpYldP23"&gt;REVENUE AND DEFERRED REVENUE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zwR9TgpzAFL" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zZSQH6QWY1V3" style="display: none"&gt;SCHEDULE OF REVENUE FROM SOURCES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260101__20260630_zsM9pTo6JLb1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20250630_zik7pBBVlyJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SoftwareDevelopmentRevenueMember_zUtlDtPVHbGh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Software development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;328,221&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;273,110&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SenseraDevicesAndCapsulesMember_zEE99jUxUVM6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Sensera devices and capsules&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,852&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0851"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SoftwareLicensingRevenueMember_zdpFv4XD6r8d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Software license&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SoftwareSupportRevenueMember_zs8DBe4zuxh6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Software supports&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,718&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--CloudHostingRevenueMember_zs7hOGunMwKa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Cloud hosting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,501&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--OtherRevenue_z40okO6W5Wz8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,254&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,679&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--Revenue_zXZeAOTTX5s" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue&lt;/span&gt; &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;488,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;407,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_znm1LrdiDSa4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FEMTO
TECHNOLOGIES INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to the Condensed Consolidated Interim Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
the six months ended June 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Expressed
in Canadian dollars)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(Unaudited)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="margin-left: auto; margin-right: auto; width: 100%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2013; REVENUE AND DEFERRED REVENUE (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--DisclosureOfRevenueWithTimingExplanatory_zsZbjZ2UHS1l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized revenues from contracts with customers in accordance with the following timing under IFRS 15:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zEz247pwpRY4" style="display: none"&gt;SCHEDULE OF REVENUE UNDER TIMING&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20260101__20260630_zXaQhrkRB0t4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250101__20250630_zJY962Fssdt2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--Revenue_hifrs-full--TimingOfTransferOfGoodsOrServicesAxis__custom--RevenueTransferredOverTimeMember_zi6j9XtI0lD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Revenue recognized over time&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;393,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;328,193&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Revenue_hifrs-full--TimingOfTransferOfGoodsOrServicesAxis__custom--RevenueTransferredAtPointInTimeMember_zJxOsVAv4CCd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Revenue recognized at a point of time&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;94,711&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;79,728&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--Revenue_zdwfFN58LuEj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;488,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;407,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zjmpH9ibPF3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--DisclosureOfDeferredRevenueExplanatory_zIDs3ZszR3T" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue represents contract liabilities for customer payments received related to services yet to be provided subsequent to the reporting
date. Significant changes in deferred revenue are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zL0sRuS9ZKw8" style="display: none"&gt;SCHEDULE OF DEFERRED REVENUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Deferred revenue, beginning&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--ContractLiabilities_iS_c20260101__20260630_zvjUCnrr2t32" style="width: 16%; text-align: right" title="Deferred revenue, beginning"&gt;145,404&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--ContractLiabilities_iS_c20250101__20251231_zkmywt9S5Ynj" style="width: 16%; text-align: right" title="Deferred revenue, beginning"&gt;140,088&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Customer payments received attributable to contract liabilities for unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ReceivablesFromContractsWithCustomer_c20260101__20260630_zscvtXvLw27i" style="text-align: right" title="Customer payments received attributable to contract liabilities for unearned revenue"&gt;19,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ReceivablesFromContractsWithCustomer_c20250101__20251231_zUXveJ5XO8c" style="text-align: right" title="Customer payments received attributable to contract liabilities for unearned revenue"&gt;182,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Revenue recognized from fulfilling contract liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RevenueReconizedFromContractLiabilities_c20260101__20260630_z4H0ikHVnXRa" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from fulfilling contract liabilities"&gt;(69,107&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RevenueReconizedFromContractLiabilities_c20250101__20251231_zCDKSpp7Sda3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from fulfilling contract liabilities"&gt;(177,337&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;Deferred revenue, ending&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--ContractLiabilities_iE_c20260101__20260630_zHnDlKAqYRqa" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue, ending"&gt;95,354&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--ContractLiabilities_iE_c20250101__20251231_zr0LnTgchNpc" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue, ending"&gt;145,404&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_za251VycEbx1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derives significant revenues from one customer, which exceeds 10% of total revenues. Revenues earned from that customer were
&lt;span id="xdx_90E_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20260101__20260630__ifrs-full--MajorCustomersAxis__custom--CustomerMember_zU61yinYKTZb" title="Revenue percentage"&gt;78&lt;/span&gt;% of total revenues for the period ended June 30, 2026 Six months ended June 30, 2025 &#x2013; &lt;span id="xdx_902_eifrs-full--PercentageOfEntitysRevenue_pid_dp_c20250101__20250630__ifrs-full--MajorCustomersAxis__custom--CustomerMember_zQ3p7BiHQzAh" title="Revenue percentage"&gt;64&lt;/span&gt;%)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRevenueExplanatory>
    <ifrs-full:DisclosureOfProductsAndServicesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000845">&lt;p id="xdx_89D_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zwR9TgpzAFL" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B6_zZSQH6QWY1V3" style="display: none"&gt;SCHEDULE OF REVENUE FROM SOURCES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260101__20260630_zsM9pTo6JLb1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250101__20250630_zik7pBBVlyJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SoftwareDevelopmentRevenueMember_zUtlDtPVHbGh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Software development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;328,221&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;273,110&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SenseraDevicesAndCapsulesMember_zEE99jUxUVM6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Sensera devices and capsules&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,852&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0851"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SoftwareLicensingRevenueMember_zdpFv4XD6r8d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Software license&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--SoftwareSupportRevenueMember_zs8DBe4zuxh6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Software supports&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,718&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--CloudHostingRevenueMember_zs7hOGunMwKa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Cloud hosting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,501&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--OtherRevenue_z40okO6W5Wz8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,254&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,679&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--Revenue_zXZeAOTTX5s" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue&lt;/span&gt; &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;488,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;407,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ifrs-full:DisclosureOfProductsAndServicesExplanatory>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_SoftwareDevelopmentRevenueMember"
      decimals="0"
      id="Fact000847"
      unitRef="CAD">328221</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_SoftwareDevelopmentRevenueMember"
      decimals="0"
      id="Fact000848"
      unitRef="CAD">273110</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_SenseraDevicesAndCapsulesMember"
      decimals="0"
      id="Fact000850"
      unitRef="CAD">3852</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_SoftwareLicensingRevenueMember"
      decimals="0"
      id="Fact000853"
      unitRef="CAD">90859</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_SoftwareLicensingRevenueMember"
      decimals="0"
      id="Fact000854"
      unitRef="CAD">79728</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_SoftwareSupportRevenueMember"
      decimals="0"
      id="Fact000856"
      unitRef="CAD">31718</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_SoftwareSupportRevenueMember"
      decimals="0"
      id="Fact000857"
      unitRef="CAD">27355</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_CloudHostingRevenueMember"
      decimals="0"
      id="Fact000859"
      unitRef="CAD">30501</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_CloudHostingRevenueMember"
      decimals="0"
      id="Fact000860"
      unitRef="CAD">24049</ifrs-full:Revenue>
    <ifrs-full:OtherRevenue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000862"
      unitRef="CAD">3254</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000863"
      unitRef="CAD">3679</ifrs-full:OtherRevenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000865"
      unitRef="CAD">488405</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000866"
      unitRef="CAD">407921</ifrs-full:Revenue>
    <FMTOF:DisclosureOfRevenueWithTimingExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000868">&lt;p id="xdx_895_ecustom--DisclosureOfRevenueWithTimingExplanatory_zsZbjZ2UHS1l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized revenues from contracts with customers in accordance with the following timing under IFRS 15:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zEz247pwpRY4" style="display: none"&gt;SCHEDULE OF REVENUE UNDER TIMING&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20260101__20260630_zXaQhrkRB0t4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250101__20250630_zJY962Fssdt2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--Revenue_hifrs-full--TimingOfTransferOfGoodsOrServicesAxis__custom--RevenueTransferredOverTimeMember_zi6j9XtI0lD3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Revenue recognized over time&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;393,694&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;328,193&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--Revenue_hifrs-full--TimingOfTransferOfGoodsOrServicesAxis__custom--RevenueTransferredAtPointInTimeMember_zJxOsVAv4CCd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Revenue recognized at a point of time&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;94,711&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;79,728&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--Revenue_zdwfFN58LuEj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;488,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;407,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FMTOF:DisclosureOfRevenueWithTimingExplanatory>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_RevenueTransferredOverTimeMember"
      decimals="0"
      id="Fact000870"
      unitRef="CAD">393694</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_RevenueTransferredOverTimeMember"
      decimals="0"
      id="Fact000871"
      unitRef="CAD">328193</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-012026-06-30_custom_RevenueTransferredAtPointInTimeMember"
      decimals="0"
      id="Fact000873"
      unitRef="CAD">94711</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30_custom_RevenueTransferredAtPointInTimeMember"
      decimals="0"
      id="Fact000874"
      unitRef="CAD">79728</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000876"
      unitRef="CAD">488405</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000877"
      unitRef="CAD">407921</ifrs-full:Revenue>
    <FMTOF:DisclosureOfDeferredRevenueExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000879">&lt;p id="xdx_89D_ecustom--DisclosureOfDeferredRevenueExplanatory_zIDs3ZszR3T" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue represents contract liabilities for customer payments received related to services yet to be provided subsequent to the reporting
date. Significant changes in deferred revenue are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zL0sRuS9ZKw8" style="display: none"&gt;SCHEDULE OF DEFERRED REVENUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Deferred revenue, beginning&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--ContractLiabilities_iS_c20260101__20260630_zvjUCnrr2t32" style="width: 16%; text-align: right" title="Deferred revenue, beginning"&gt;145,404&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--ContractLiabilities_iS_c20250101__20251231_zkmywt9S5Ynj" style="width: 16%; text-align: right" title="Deferred revenue, beginning"&gt;140,088&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Customer payments received attributable to contract liabilities for unearned revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ReceivablesFromContractsWithCustomer_c20260101__20260630_zscvtXvLw27i" style="text-align: right" title="Customer payments received attributable to contract liabilities for unearned revenue"&gt;19,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ReceivablesFromContractsWithCustomer_c20250101__20251231_zUXveJ5XO8c" style="text-align: right" title="Customer payments received attributable to contract liabilities for unearned revenue"&gt;182,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt"&gt;Revenue recognized from fulfilling contract liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RevenueReconizedFromContractLiabilities_c20260101__20260630_z4H0ikHVnXRa" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from fulfilling contract liabilities"&gt;(69,107&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RevenueReconizedFromContractLiabilities_c20250101__20251231_zCDKSpp7Sda3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue recognized from fulfilling contract liabilities"&gt;(177,337&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;Deferred revenue, ending&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--ContractLiabilities_iE_c20260101__20260630_zHnDlKAqYRqa" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue, ending"&gt;95,354&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--ContractLiabilities_iE_c20250101__20251231_zr0LnTgchNpc" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred revenue, ending"&gt;145,404&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FMTOF:DisclosureOfDeferredRevenueExplanatory>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000881"
      unitRef="CAD">145404</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000883"
      unitRef="CAD">140088</ifrs-full:ContractLiabilities>
    <FMTOF:ReceivablesFromContractsWithCustomer
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000885"
      unitRef="CAD">19057</FMTOF:ReceivablesFromContractsWithCustomer>
    <FMTOF:ReceivablesFromContractsWithCustomer
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000887"
      unitRef="CAD">182653</FMTOF:ReceivablesFromContractsWithCustomer>
    <FMTOF:RevenueReconizedFromContractLiabilities
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000889"
      unitRef="CAD">-69107</FMTOF:RevenueReconizedFromContractLiabilities>
    <FMTOF:RevenueReconizedFromContractLiabilities
      contextRef="From2025-01-012025-12-31"
      decimals="0"
      id="Fact000891"
      unitRef="CAD">-177337</FMTOF:RevenueReconizedFromContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2026-06-30"
      decimals="0"
      id="Fact000893"
      unitRef="CAD">95354</ifrs-full:ContractLiabilities>
    <ifrs-full:ContractLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000895"
      unitRef="CAD">145404</ifrs-full:ContractLiabilities>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2026-01-012026-06-30_custom_CustomerMember"
      decimals="INF"
      id="Fact000897"
      unitRef="Pure">0.78</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2025-01-012025-06-30_custom_CustomerMember"
      decimals="INF"
      id="Fact000899"
      unitRef="Pure">0.64</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:DisclosureOfCostOfSalesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000901">&lt;p id="xdx_806_eifrs-full--DisclosureOfCostOfSalesExplanatory_zq8RyncwCUcg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_82C_zuuoDa2nEVy8"&gt;COST OF REVENUE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--DisclosureOfDetailedInformationAboutCostOfSalesExplanatory_z8gO8vGq6RSj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
of revenue incurred are comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zZUjwXovVuoc" style="display: none"&gt;SCHEDULE OF COST OF REVENUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20260101__20260630_zQTMfT26yHAb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20250101__20250630_z7nKe6iOasn6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--WagesAndSalaries_maCOSz6q0_zXmahJOWnPV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Salaries and benefits&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;301,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;316,043&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SenseraCosts_maCOSz6q0_zh7nB3Ja4uI7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Sensera costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SubcontractorsExpenseRecovery_maCOSz6q0_zCXP0V860cB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Subcontractors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SoftwareAndOther_maCOSz6q0_zEstaUylucIb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Software and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationAndAmortisationExpense_maCOSz6q0_zzPv7jWL0kG3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0pt"&gt;Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,122&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;818&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--CostOfSales_iT_mtCOSz6q0_zv0wvHD7a1Ji" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;400,048&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;373,208&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zeOBkVW48b8b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



</ifrs-full:DisclosureOfCostOfSalesExplanatory>
    <FMTOF:DisclosureOfDetailedInformationAboutCostOfSalesExplanatory contextRef="From2026-01-01to2026-06-30" id="Fact000903">&lt;p id="xdx_898_ecustom--DisclosureOfDetailedInformationAboutCostOfSalesExplanatory_z8gO8vGq6RSj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost
of revenue incurred are comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zZUjwXovVuoc" style="display: none"&gt;SCHEDULE OF COST OF REVENUE&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20260101__20260630_zQTMfT26yHAb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20250101__20250630_z7nKe6iOasn6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--WagesAndSalaries_maCOSz6q0_zXmahJOWnPV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-left: 0pt"&gt;Salaries and benefits&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;301,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;316,043&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SenseraCosts_maCOSz6q0_zh7nB3Ja4uI7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Sensera costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--SubcontractorsExpenseRecovery_maCOSz6q0_zCXP0V860cB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Subcontractors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--SoftwareAndOther_maCOSz6q0_zEstaUylucIb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Software and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--DepreciationAndAmortisationExpense_maCOSz6q0_zzPv7jWL0kG3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0pt"&gt;Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,122&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;818&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--CostOfSales_iT_mtCOSz6q0_zv0wvHD7a1Ji" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;400,048&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;373,208&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FMTOF:DisclosureOfDetailedInformationAboutCostOfSalesExplanatory>
    <ifrs-full:WagesAndSalaries
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000905"
      unitRef="CAD">301851</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000906"
      unitRef="CAD">316043</ifrs-full:WagesAndSalaries>
    <FMTOF:SenseraCosts
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000908"
      unitRef="CAD">75851</FMTOF:SenseraCosts>
    <FMTOF:SubcontractorsExpenseRecovery
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000912"
      unitRef="CAD">40174</FMTOF:SubcontractorsExpenseRecovery>
    <FMTOF:SoftwareAndOther
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000914"
      unitRef="CAD">21224</FMTOF:SoftwareAndOther>
    <FMTOF:SoftwareAndOther
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000915"
      unitRef="CAD">16173</FMTOF:SoftwareAndOther>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000917"
      unitRef="CAD">1122</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000918"
      unitRef="CAD">818</ifrs-full:DepreciationAndAmortisationExpense>
    <ifrs-full:CostOfSales
      contextRef="From2026-01-01to2026-06-30"
      decimals="0"
      id="Fact000920"
      unitRef="CAD">400048</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2025-01-012025-06-30"
      decimals="0"
      id="Fact000921"
      unitRef="CAD">373208</ifrs-full:CostOfSales>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000249"
          xlink:label="Fact000249"
          xlink:type="locator"/>
        <link:footnote id="Footnote000280" xlink:label="Footnote000280" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Adjusted
    to reflect <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIEludGVyaW0gU3RhdGVtZW50cyBvZiBMb3NzIGFuZCBDb21wcmVoZW5zaXZlIExvc3MgKFVuYXVkaXRlZCkgKFBhcmVudGhldGljYWwpAA__"
  id="xdx_90D_ecustom--StockholdersEquityReverseStockSplitDescription_c20250417__20250417_zoaVB55Ow99b"
  title="Reverse stock split">one (1) for five hundreds (500) reverse stock split</xhtml:span> in April 2025 (see Note 1)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000249"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000251"
          xlink:label="Fact000251"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000251"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000253"
          xlink:label="Fact000253"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000253"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000255"
          xlink:label="Fact000255"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000255"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000257"
          xlink:label="Fact000257"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000257"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000259"
          xlink:label="Fact000259"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000259"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000261"
          xlink:label="Fact000261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000261"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000263"
          xlink:label="Fact000263"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000263"
          xlink:to="Footnote000280"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000291"
          xlink:label="Fact000291"
          xlink:type="locator"/>
        <link:footnote id="Footnote000433" xlink:label="Footnote000433" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Adjusted
    to reflect <xhtml:span
  class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIEludGVyaW0gU3RhdGVtZW50cyBvZiBDaGFuZ2VzIGluIFNoYXJlaG9sZGVycycgRXF1aXR5IChEZWZpY2l0KSAoVW5hdWRpdGVkKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_907_ecustom--StockholdersEquityReverseStockSplitDescription_c20250417__20250417_zK9DCUL3YsVk"
  title="Reverse stock split">one (1) for five hundreds (500) reverse stock split</xhtml:span> in April 2025 (see Note 1)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000291"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000300"
          xlink:label="Fact000300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000300"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000316"
          xlink:label="Fact000316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000316"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000332"
          xlink:label="Fact000332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000332"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000341"
          xlink:label="Fact000341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000341"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000359"
          xlink:label="Fact000359"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000359"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000375"
          xlink:label="Fact000375"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000375"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000384"
          xlink:label="Fact000384"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000384"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000393"
          xlink:label="Fact000393"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000393"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000432"
          xlink:label="Fact000432"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000432"
          xlink:to="Footnote000433"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
